Fibrosis and cirrhosis of liver

K11_FIBROCHIRLIV

cirrhosis of liver: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K74 Hospital discharge: ICD-9 — 571[5-6] Hospital discharge: ICD-8 — 5719 Cause of death: ICD-10 — K74 Cause of death: ICD-9 — 571[5-6] Cause of death: ICD-8 — 5719 2 out of 7 registries used, show all original rules.	2738
4. Check minimum number of events None	2738
5. Include endpoints None	2738
6. Filter based on genotype QC (FinnGen only)	2738

Control definitions (FinnGen only)

Control exclude: K11_LIVER

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K70-K77
Name in latin: Fibrosis et cirrhosis hepatis

NAME	K11_FIBROCHIRLIV
CONTROL_EXCLUDE	K11_LIVER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K74
HD_ICD_9	571[5-6]
HD_ICD_8	5719
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K74
COD_ICD_9	571[5-6]
COD_ICD_8	5719
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fibrosis and cirrhosis of liver based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23725	11371	11894
Only index persons	16446	8181	8265
Unadjusted period prevalence (%)
Whole population	0.33	0.33	0.33
Only index persons	0.31	0.30	0.32
Median age at first event (years)
Whole population	63.88	64.27	63.53
Only index persons	63.60	63.15	64.04

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2738	1407	1331
Unadjusted period prevalence (%)	0.53	0.48	0.59
Median age at first event (years)	62.66	60.36	65.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2417: Matched controls
24169

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K74.3

ICD-10 Finland

Primary biliary cirrhosis

9896.7

323.0

717

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

12.5

323.0

802

921

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

+∞

323.0

1526

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

536.0

323.0

478

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

7.3

323.0

1538

4677

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

61.8

323.0

591

126

A05AA02

ATC

ursodeoxycholic acid; oral

206.5

323.0

704

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

1887.4

323.0

454

C03DA01

ATC

spironolactone; oral

10.7

323.0

934

1348

R18

ICD-10 Finland

Ascites

42.7

323.0

462

133

K76.9

ICD-10 Finland

Liver disease, unspecified

428.2

273.2

269

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.1

239.3

761

1686

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

6.4

236.9

716

1483

C03CA01

ATC

furosemide; systemic

4.3

233.0

1247

4804

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

59.3

232.7

274

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

207.3

196

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

27.5

193.5

270

110

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

657.4

187.5

183

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

1840.8

171.9

165

Z94.4

ICD-10 Finland

Liver transplant status

352.6

166.3

166

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

50.9

166.2

201

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

91.0

159.7

177

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

1607.9

153.8

148

JJC00

NOMESCO Finland

Allogenic transplantation of liver

774.7

149.8

146

A06AD11

ATC

lactulose; oral

4.1

144.3

681

2130

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

+∞

140.0

133

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.3

136.3

914

3769

103

Kela drug reimbursment

Diabetes, insulin-treated

3.1

131.4

1001

4492

A10AE04

ATC

insulin glargine; parenteral

4.6

121.6

477

1228

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

12.8

114.3

210

178

K72.9

ICD-10 Finland

Hepatic failure, unspecified

584.8

113.9

112

D64.9

ICD-10 Finland

Anaemia, unspecified

4.3

113.1

478

1316

K83.0

ICD-10 Finland

Cholangitis

18.1

109.6

174

103

127

Kela drug reimbursment

Transplant complication

15.2

101.8

173

122

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

4.8

100.7

371

883

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

+∞

98.6

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

497.2

97.1

D97

ICPC

Liver disease NOS

51.9

94.8

114

A07AA11

ATC

rifaximin; oral

+∞

94.4

UJF32

NOMESCO Finland

Coloscopy

2.7

93.2

874

4243

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.7

92.7

843

4015

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

325.1

92.5

K92.0

ICD-10 Finland

Haematemesis

9.2

91.9

200

234

K72.1

ICD-10 Finland

Chronic hepatic failure

+∞

89.1

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

57.7

88.9

105

A10BA02

ATC

metformin; oral

2.5

84.2

910

4716

A07EA06

ATC

budesonide; oral, local oral

7.5

83.8

208

300

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

38.2

83.0

106

K70.4

ICD-10 Finland

Alcoholic hepatic failure

836.2

83.0

K76.7

ICD-10 Finland

Hepatorenal syndrome

+∞

81.7

B18.2

ICD-10 Finland

Chronic viral hepatitis C

22.5

81.7

120

T90

ICPC

Diabetes non-insulin dependent

2.6

81.1

781

3781

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.6

81.1

408

1278

L04AX01

ATC

azathioprine; systemic

5.8

81.0

244

457

C07AA05

ATC

propranolol; systemic

2.8

80.7

613

2577

N02AX02

ATC

tramadol; systemic, rectal

2.3

80.0

1235

7595

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

11.9

79.8

151

135

L04AA06

ATC

mycophenolic acid; systemic

11.4

78.4

151

140

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

19.4

77.8

120

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

11.4

77.4

149

138

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

76.6

1253

7856

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.4

75.9

296

736

K92.1

ICD-10 Finland

Melaena

4.9

74.4

261

581

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

4.0

73.9

328

919

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

13.2

73.6

132

105

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.0

72.9

322

898

A10BH01

ATC

sitagliptin; oral

3.4

71.5

391

1299

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

687.1

68.3

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.2

67.1

974

5667

JJ5AT

NOMESCO Finland

341.3

66.8

K70.1

ICD-10 Finland

Alcoholic hepatitis

655.3

65.2

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

17.5

65.2

104

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

63.7

655

3207

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

62.8

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

11.1

62.8

122

115

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

88.8

62.2

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

613.1

61.0

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

60.3

508

2220

L04AD01

ATC

ciclosporin; systemic

8.2

59.5

137

175

UJF30

NOMESCO Finland

Ileoscopy through colon

3.2

59.2

341

1167

A02BC02

ATC

pantoprazole; systemic

2.1

58.7

1676

12641

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.6

58.1

178

338

C07AG02

ATC

carvedilol; oral

3.8

58.0

265

754

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.2

58.0

239

620

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.4

57.7

142

201

TK800

NOMESCO Finland

Hemodialysis

7.1

57.3

145

214

WW500

NOMESCO Finland

Blood transfusion

5.0

54.5

186

399

A10BB12

ATC

glimepiride; oral

3.4

54.3

285

907

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

9.4

54.2

115

128

K70.0

ICD-10 Finland

Alcoholic fatty liver

58.7

53.7

A10AE05

ATC

insulin detemir; parenteral

4.0

53.5

230

619

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.9

52.7

183

400

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.8

51.7

182

403

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

10.6

51.5

102

100

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.8

50.7

363

1429

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.5

50.6

253

773

JN3AD

NOMESCO Finland

Abdominal CT examination

3.3

50.6

285

954

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

48.0

428

1909

5716A

ICD-9 Finland

Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]

+∞

47.0

A46

ICD-10 Finland

Erysipelas

2.4

46.3

440

2023

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.5

46.3

229

693

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

86.9

46.0

J01MA02

ATC

ciprofloxacin; systemic

1.9

45.8

1029

6817

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.3

45.3

473

2282

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.1

44.4

102

130

ZX120

NOMESCO Finland

Intravenous

2.8

44.1

315

1232

UJK02

NOMESCO Finland

ERCP

5.7

43.5

130

239

R50.9

ICD-10 Finland

Fever, unspecified

2.4

43.2

411

1885

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.6

43.0

350

1478

K76.6

ICD-10 Finland

Portal hypertension

+∞

42.8

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

42.5

335

1387

JJA20

NOMESCO Finland

Open biopsy of liver

38.7

42.0

A41.9

ICD-10 Finland

Sepsis, unspecified

4.5

41.8

156

366

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.7

41.2

146

325

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

41.1

346

1484

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.5

40.7

350

1519

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.2

40.3

470

2375

E66.00

ICD-10 Finland

Metabolic syndrome

3.5

40.1

200

607

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

12.8

40.0

H02AB06

ATC

prednisolone; systemic

1.8

39.5

1172

8373

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

39.2

849

5466

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.9

39.0

112

196

WX892

NOMESCO Finland

Monitored bed care

2.9

39.0

259

962

I81

ICD-10 Finland

Portal vein thrombosis

32.5

38.9

C10AC01

ATC

colestyramine; oral

5.2

38.2

122

243

K29.7

ICD-10 Finland

Gastritis, unspecified

4.2

38.1

153

386

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

38.0

694

4194

K29.6

ICD-10 Finland

Other gastritis

9.8

38.0

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

37.8

214

714

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

36.5

JN4CD

NOMESCO Finland

Very extensive body CT

3.9

36.0

157

426

R94.5

ICD-10 Finland

Abnormal results of liver function studies

10.7

35.9

SPAT1262

SPAT

Handing over of treatment supplies

2.0

35.7

522

2887

57199

ICD-8 Finland

Cirrhosis of liver, Unspecified

+∞

35.5

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.4

35.4

180

554

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

96.5

34.8

160

Kela drug reimbursment

exenatide

5.6

34.7

104

192

N02AA05

ATC

oxycodone; systemic

2.1

33.5

428

2233

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

33.4

165

497

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

6.7

32.7

131

R4110

NOMESCO Finland

Physiotherapy

1.8

32.7

689

4338

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

31.2

32.6

E87.5

ICD-10 Finland

Hyperkalaemia

6.1

32.4

155

I50.0

ICD-10 Finland

Congestive heart failure

2.7

32.1

229

889

205

Kela drug reimbursment

Chronic hypertension

1.8

31.9

761

4977

UJD02

NOMESCO Finland

Gastroscopy

3.2

31.7

176

578

198

Kela drug reimbursment

Sorafenib

24.9

31.4

WX002

NOMESCO Finland

Sedation and analgesia

1.9

31.1

537

3141

K76.89

ICD-10 Finland

Other specified diseases of liver

316.8

30.9

M04AA01

ATC

allopurinol; systemic

2.1

30.6

372

1895

R06.0

ICD-10 Finland

Dyspnoea

1.8

30.4

626

3891

57198

ICD-8 Finland

Cirrhosis of liver, Alia definita, alcoholismo non indicato

+∞

30.3

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

30.0

224

892

I86.4

ICD-10 Finland

Gastric varices

306.1

29.9

Z51.5

ICD-10 Finland

Palliative care

2.8

29.5

202

763

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

50.7

29.4

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

29.0

454

2557

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.2

28.9

159

519

J01MA12

ATC

levofloxacin; systemic

1.9

28.7

505

2964

177

Kela drug reimbursment

Insulin glargine 300 U / ml

5.3

28.7

172

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.2

28.6

157

512

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

28.6

477

2748

K51.5

ICD-10 Finland

Left sided colitis

4.7

28.5

217

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.3

28.1

108

262

A10BH05

ATC

linagliptin; oral

3.1

28.0

160

536

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

28.0

256

1138

J01FF01

ATC

clindamycin; systemic

1.7

27.9

663

4296

H02AB04

ATC

methylprednisolone; systemic

2.0

27.9

390

2100

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.7

27.9

125

348

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

15.1

27.8

G93.4

ICD-10 Finland

Encephalopathy, unspecified

25.7

27.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

27.4

563

3480

WX872

NOMESCO Finland

Intensive care

3.0

27.4

164

568

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.8

27.4

121

333

57309

ICD-8 Finland

Other diseases of liver, Unspecified

+∞

27.1

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

62.8

27.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

26.4

420

2372

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.3

26.4

137

429

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.7

26.3

120

339

K74.4

ICD-10 Finland

Secondary biliary cirrhosis

+∞

26.1

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

+∞

26.1

JN4BD

NOMESCO Finland

Extensive body CT

2.1

25.6

314

1598

C07AB07

ATC

bisoprolol; oral

1.6

25.5

1164

8953

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

28.7

25.4

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

25.0

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

18.4

24.8

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.8

24.7

106

285

E66.01

ICD-10 Finland

Obesity due to excess calories

2.6

24.6

196

806

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

24.4

127

399

TJA10

NOMESCO Finland

Laparocentesis

18.8

24.3

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.2

24.3

230

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

24.2

587

3798

A10BG03

ATC

pioglitazone; oral

3.9

24.0

100

262

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

242.3

23.7

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.8

23.4

159

598

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.4

22.9

195

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.9

22.8

142

505

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.6

22.8

178

N19

ICD-10 Finland

Unspecified kidney failure

3.4

22.7

112

338

R04.0

ICD-10 Finland

Epistaxis

2.4

22.4

206

915

A28

ICPC

Limited function/disability NOS

1.9

22.3

386

2233

A10BJ02

ATC

liraglutide; parenteral

4.0

22.3

229

R60.0

ICD-10 Finland

Localized oedema

2.0

22.3

294

1537

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

35.4

22.1

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.0

21.9

131

453

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

21.9

358

2028

K74.1

ICD-10 Finland

Hepatic sclerosis

+∞

21.9

UJF92

NOMESCO Finland

Capsular endoscopy

4.7

21.9

163

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

21.8

140

507

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.4

21.7

108

328

L01XE05

ATC

[U] sorafenib; oral

22.4

21.7

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

4.0

21.6

221

JCA20

NOMESCO Finland

Ligature of oesophageal varices

221.9

21.6

P15

ICPC

Chronic alcohol abuse

4.1

21.6

217

N17.8

ICD-10 Finland

Other acute renal failure

7.0

21.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

21.3

321

1764

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.1

21.1

117

385

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

20.8

372

2176

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

20.8

131

470

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.1

20.6

129

E66.9

ICD-10 Finland

Obesity, unspecified

3.6

20.6

272

A10BX07

ATC

[U] liraglutide; parenteral

5.4

20.6

117

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

7.0

20.2

162

Kela drug reimbursment

liraglutide

6.1

20.1

A10BD07

ATC

metformin and sitagliptin; systemic

2.7

20.1

142

546

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

20.0

503

3265

A07EC02

ATC

mesalazine; oral, rectal

2.6

19.9

149

593

K83.1

ICD-10 Finland

Obstruction of bile duct

5.4

19.8

114

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

+∞

19.8

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

+∞

19.8

I85

ICD-10 Finland

Oesophageal varices

+∞

19.8

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

74.1

19.7

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.4

19.5

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

8.2

19.4

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.8

19.4

224

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

19.1

109

365

A10BX04

ATC

[U] exenatide; parenteral

6.1

19.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.5

19.0

155

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

19.0

671

4753

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

34.6

18.9

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.3

18.9

292

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

18.9

244

1263

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.4

18.8

166

723

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

28.0

18.7

S97

ICPC

Chronic ulcer skin

2.5

18.6

150

621

WX882

NOMESCO Finland

High dependency care

3.5

18.6

258

AA1AD

NOMESCO Finland

CT of head and brain

1.6

18.4

558

3798

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.6

18.3

135

531

E0000UV

ATC

1.5

18.2

846

6371

J01DB01

ATC

cefalexin; oral

1.5

18.2

1847

16384

JN4AD

NOMESCO Finland

Body CT examination

2.1

18.2

211

1042

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

18.2

1380

11512

E66.8

ICD-10 Finland

Other obesity

2.7

18.2

125

475

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

18.1

277

1529

A10BK03

ATC

empagliflozin; oral

2.2

17.9

186

873

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

67.1

17.7

D73.1

ICD-10 Finland

Hypersplenism

67.1

17.7

UJK12

NOMESCO Finland

Peroral cholangioscopy

14.7

17.6

A12BA01

ATC

potassium chloride; oral

2.6

17.5

130

514

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.5

17.4

144

606

E000001

ATC

1.7

17.4

435

2804

R41.0

ICD-10 Finland

Disorientation, unspecified

3.2

17.3

301

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

17.2

164

742

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

17.2

731

5386

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

17.1

166

756

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

17.0

869

6653

N18.8

ICD-10 Finland

Other chronic renal failure

3.1

16.9

311

N05CD07

ATC

temazepam; oral

1.8

16.9

322

1912

N05CF01

ATC

zopiclone; oral

1.5

16.9

740

5479

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

16.8

145

622

L04AA01

ATC

[U] ciclosporin; systemic

4.3

16.8

151

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

16.8

190

930

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

16.7

589

4149

5719X

ICD-9 Finland

Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol

+∞

16.7

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.0

16.6

320

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

7.7

16.6

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

16.6

277

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.7

16.5

203

V03AE01

ATC

polystyrene sulfonate; oral

5.2

16.5

100

A41.8

ICD-10 Finland

Other specified sepsis

4.2

16.5

154

A10BB01

ATC

glibenclamide; oral

2.6

16.5

124

494

RS120

NOMESCO Finland

23.2

16.4

RS220

NOMESCO Finland

5.2

16.2

M10.9

ICD-10 Finland

Gout, unspecified

2.2

16.2

168

792

R02

ICPC

Shortness of breath/dyspnoea

1.8

16.1

284

1645

R53

ICD-10 Finland

Malaise and fatigue

1.6

16.0

450

2992

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.2

15.9

274

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.3

15.9

247

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.1

15.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

15.8

290

1702

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

15.8

671

4924

6611

FHL

Needle biopsy in the operating room

60.4

15.8

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

15.7

126

520

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

15.7

344

2132

E87.6

ICD-10 Finland

Hypokalaemia

3.1

15.7

288

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.6

15.6

119

478

5715A

ICD-9 Finland

Chronic liver disease and cirrhosis, Cirrhosis of liver without mention of alcohol

+∞

15.6

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

22.2

15.5

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

15.5

342

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.0

15.4

315

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.8

15.4

101

374

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

7.7

15.4

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

15.3

103

386

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

15.3

253

1434

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.6

15.2

192

I50

ICD-10 Finland

Heart failure

2.9

15.1

330

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

15.1

309

1873

A10AB06

ATC

insulin glulisine; parenteral

5.5

15.1

L28

ICPC

Limited function/disability (L)

1.7

15.1

373

2392

A08

ICPC

Swelling

2.6

15.0

113

454

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

5.6

14.9

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

31.9

14.8

WVA20

NOMESCO Finland

Medicine administration

3.6

14.8

191

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

4.0

14.8

151

ZX108

NOMESCO Finland

Inhalation

7.2

14.8

L04AA05

ATC

[U] tacrolimus; systemic

21.2

14.6

D07AC01

ATC

betamethasone; topical

1.5

14.6

741

5620

K76.1

ICD-10 Finland

Chronic passive congestion of liver

+∞

14.6

5714X

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]

+∞

14.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

14.5

248

N05BA04

ATC

oxazepam; oral

1.5

14.4

527

3725

JAH00

NOMESCO Finland

Laparotomy

3.0

14.4

276

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.5

14.4

112

458

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.2

14.3

131

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

11.4

14.3

3A422

NOMESCO Finland

42.7

14.1

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

14.0

244

1405

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

7.3

14.0

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

13.9

158

774

M34.1

ICD-10 Finland

CR(E)ST syndrome

7.8

13.8

B01AA03

ATC

warfarin; systemic

1.5

13.7

459

3175

D64.8

ICD-10 Finland

Other specified anaemias

4.0

13.7

137

JAH01

NOMESCO Finland

Laparoscopy

2.5

13.7

107

437

K50.8

ICD-10 Finland

Other Crohn disease

4.2

13.7

123

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

6.4

13.7

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.3

13.6

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

13.6

A10BJ06

ATC

semaglutide; parenteral

2.8

13.5

324

C09AA02

ATC

enalapril; systemic

1.5

13.5

466

3246

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

11.0

13.5

SPAT1255

SPAT

Intravenous administration of medicine

2.0

13.4

164

831

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

6.0

13.3

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

13.3

517

3696

F10.24

ICD-10 Finland

Alcohol depence active use

4.3

13.2

113

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

13.2

135

634

3AC01

NOMESCO Finland

4.8

13.1

323

Kela drug reimbursment

Sorafenib

40.3

13.1

M05BA04

ATC

alendronic acid; oral

1.9

13.1

205

1140

B80

ICPC

Iron deficiency anaemia

3.7

13.0

154

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.9

13.0

139

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.4

13.0

191

K65.0

ICD-10 Finland

Acute peritonitis

4.7

12.9

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.8

12.9

310

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

12.8

446

3105

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

12.8

226

1306

C01AA05

ATC

digoxin; systemic

1.9

12.8

195

1074

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.6

12.7

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

15.5

12.6

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.4

12.6

110

480

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.6

12.5

159

R4190

NOMESCO Finland

Nutritional therapy

2.7

12.5

335

K75.3

ICD-10 Finland

Granulomatous hepatitis, not elsewhere classified

+∞

12.5

A02BC01

ATC

omeprazole; systemic

1.4

12.5

611

4577

B01AB05

ATC

enoxaparin; parenteral

1.4

12.4

678

5190

A10BK01

ATC

dapagliflozin; oral

2.3

12.3

111

491

SPAT1265

SPAT

Breathalyser

6.0

12.2

B82

ICPC

Anaemia other/unspecified

2.9

12.2

251

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.0

12.2

245

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

5.0

12.2

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.8

12.1

138

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

5.1

12.1

A10BJ05

ATC

dulaglutide; parenteral

6.1

12.1

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

6.1

12.1

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

5.4

12.1

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

11.1

12.0

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

46.9

11.9

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

11.8

107

473

T89

ICPC

Diabetes insulin dependent

2.6

11.8

340

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

11.8

E66.0

ICD-10 Finland

Obesity due to excess calories

4.6

11.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

11.7

157

823

K51.8

ICD-10 Finland

Other ulcerative colitis

4.3

11.6

N06AX11

ATC

mirtazapine; oral

1.4

11.6

657

5045

J94.8

ICD-10 Finland

Other specified pleural conditions

3.5

11.6

154

3A064

NOMESCO Finland

11.1

11.5

C08CA01

ATC

amlodipine; oral

1.4

11.5

818

6539

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

11.5

115

534

K73.89

ICD-10 Finland

Other long-term hepatitis, not classified differently

+∞

11.5

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

+∞

11.5

K71.9

ICD-10 Finland

Toxic liver disease, unspecified

+∞

11.5

K76.4

ICD-10 Finland

Peliosis hepatis

+∞

11.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

11.4

372

2546

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

120.6

11.4

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

11.4

244

1499

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

15.1

11.3

N30.0

ICD-10 Finland

Acute cystitis

1.6

11.3

287

1847

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

35.2

11.3

D69.5

ICD-10 Finland

Secondary thrombocytopenia

10.6

11.3

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

10.6

11.3

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

9.6

11.2

UJF02

NOMESCO Finland

Peroral enteroscopy

6.2

11.2

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

5.7

11.2

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

3.9

11.2

113

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.1

11.1

127

628

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

11.0

110

511

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.1

11.0

119

570

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

11.0

237

1458

N05BA01

ATC

diazepam; systemic, rectal

1.6

11.0

287

1860

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.0

11.0

215

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.1

11.0

200

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

6.9

10.8

A10BH02

ATC

vildagliptin; oral

3.0

10.8

211

C09AA05

ATC

ramipril; oral

1.4

10.8

558

4206

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

10.8

164

903

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.9

10.8

K65.9

ICD-10 Finland

Peritonitis, unspecified

10.6

10.8

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

8.9

10.8

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

4.2

10.7

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

10.7

187

2934

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.7

10.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

10.7

273

N06AX16

ATC

venlafaxine; oral

1.6

10.7

255

1615

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.9

10.7

151

810

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.3

10.7

165

E83.1

ICD-10 Finland

Disorders of iron metabolism

6.7

10.7

K55.2

ICD-10 Finland

Angiodysplasia of colon

6.7

10.7

K07

ICPC

Swollen ankles/oedema

2.2

10.6

107

499

SPAT1254

SPAT

Administration of medicine

1.6

10.6

320

2150

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

10.6

260

1657

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.0

10.6

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.0

10.6

R60.1

ICD-10 Finland

Generalized oedema

7.0

10.6

TGC00

NOMESCO Finland

Bronchial lavation

2.7

10.5

270

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

10.5

159

875

TK810

NOMESCO Finland

Hemofiltration

6.2

10.4

H02AB09

ATC

hydrocortisone; systemic

3.1

10.4

179

5714B

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]

+∞

10.4

K75.0

ICD-10 Finland

Abscess of liver

+∞

10.4

I98.2

ICD-10 Finland

Oesophageal varices without bleeding in diseases classified elsewhere

+∞

10.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

10.4

228

1408

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.9

10.4

213

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

12.1

10.3

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

32.7

10.3

C02EA02

ATC

2.1

10.3

114

554

Z72.1

ICD-10 Finland

Alcohol use

4.4

10.3

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.3

10.3

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

18.9

10.3

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.8

10.2

D25

ICPC

Abdominal distension

3.3

10.2

154

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

23.5

10.2

N07BB01

ATC

disulfiram; oral

2.3

10.2

421

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

10.2

368

2576

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

10.2

226

1398

B03XA02

ATC

darbepoetin alfa; parenteral

3.1

10.2

182

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.6

10.2

123

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

7.5

10.2

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.7

10.1

Z94.0

ICD-10 Finland

Kidney transplant status

3.9

10.1

104

H3600, E113

ICD-10 Finland

3.7

10.1

114

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

10.1

134

702

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

10.0

181

1056

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.8

10.0

219

RD210

NOMESCO Finland

3.2

10.0

157

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.1

10.0

112

549

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

10.0

206

1252

L04AA10

ATC

sirolimus; oral

40.2

10.0

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

10.0

174

E000006

ATC

1.9

9.9

149

816

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

16.8

9.9

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

12.2

9.8

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.6

9.8

122

5739X

ICD-9 Finland

Other disorders of liver, Unspecified disorder of liver

20.1

9.8

D05AX52

ATC

calcipotriol, combinations; topical

2.0

9.8

126

653

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

7.0

9.8

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

9.8

217

1344

R03AC02

ATC

salbutamol; inhalant

1.3

9.8

1079

9171

WX402

NOMESCO Finland

General anaesthesia

1.5

9.7

340

2360

WX419

NOMESCO Finland

Other general anesthesy

4.0

9.7

A07AA09

ATC

vancomycin; oral

3.9

9.7

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

3.8

9.7

103

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.7

9.7

236

N06AB04

ATC

citalopram; systemic

1.4

9.7

432

3159

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

4.2

9.7

EBA10

NOMESCO Finland

Surgical removal of tooth

1.7

9.6

189

1129

K02.2

ICD-10 Finland

Caries of cementum

2.1

9.6

105

510

N05AH04

ATC

quetiapine; oral

1.5

9.6

297

2006

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.1

9.6

168

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

9.4

656

5192

2BB01

NOMESCO Finland

100.4

9.4

K75.2

ICD-10 Finland

Nonspecific reactive hepatitis

100.4

9.4

5718X

ICD-9 Finland

Chronic liver disease and cirrhosis, Other chronic nonalcoholic liver disease

+∞

9.4

57300

ICD-8 Finland

Other diseases of liver, Hepatitis NUD

+∞

9.4

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

+∞

9.4

K73.8

ICD-10 Finland

Other chronic hepatitis, not elsewhere classified

+∞

9.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

9.4

168

977

K65.8

ICD-10 Finland

Other peritonitis

12.4

9.4

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.5

9.3

272

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.1

9.3

166

R11

ICD-10 Finland

Nausea and vomiting

1.8

9.3

162

934

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.3

9.3

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.7

9.3

224

Z72.2

ICD-10 Finland

Drug use

9.5

9.3

K08.3

ICD-10 Finland

Retained dental root

1.8

9.2

149

838

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.1

9.2

A11CC03

ATC

alfacalcidol; systemic

2.6

9.2

259

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.0

9.2

JKA20

NOMESCO Finland

Cholecystectomy

2.5

9.2

286

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

9.2

137

749

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.3

9.1

690

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.1

9.1

152

F05.9

ICD-10 Finland

Delirium, unspecified

3.0

9.1

178

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

6.3

9.1

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.4

9.0

328

A10BX02

ATC

repaglinide; oral

3.5

9.0

115

H02AB07

ATC

prednisone; oral

1.5

9.0

311

2154

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

9.0

197

1217

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

4.9

9.0

K80.8

ICD-10 Finland

Other cholelithiasis

3.1

9.0

148

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

9.0

203

1267

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.4

9.0

121

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

8.9

304

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

8.9

363

2602

N03AX16

ATC

pregabalin; oral

1.4

8.9

499

3805

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

12.6

8.9

C03AA03

ATC

hydrochlorothiazide; oral

1.6

8.8

214

1360

C07AB02

ATC

metoprolol; systemic

1.4

8.8

454

3406

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.3

8.8

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

10.7

8.8

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.6

8.8

231

E87.2

ICD-10 Finland

Acidosis

6.3

8.8

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.6

8.7

K55.8

ICD-10 Finland

Other vascular disorders of intestine

5.6

8.7

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.6

8.7

103

M01AB01

ATC

indometacin; systemic, rectal

1.7

8.7

184

1124

A10BD03

ATC

metformin and rosiglitazone; systemic

3.0

8.7

157

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.6

8.7

233

E86

ICD-10 Finland

Volume depletion

2.6

8.7

233

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

14.1

8.7

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

2.0

8.7

109

561

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

8.7

172

1033

D07AD01

ATC

clobetasol; topical

1.5

8.6

316

2216

P01AB01

ATC

metronidazole; oral, rectal

1.3

8.6

804

6633

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.0

8.6

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

8.6

379

2758

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

16.3

8.5

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.8

8.5

198

XF612

NOMESCO Finland

Measurement of central venous pressure

9.0

8.5

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

10.1

8.5

K02.9

ICD-10 Finland

Dental caries, unspecified

3.3

8.5

121

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

8.5

343

2452

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.2

8.5

376

B17.1

ICD-10 Finland

Acute hepatitis C

20.1

8.5

R03BB04

ATC

tiotropium bromide; inhalant

1.6

8.4

224

1456

A98

ICPC

Health maint/preventive medicine

0.7

8.4

1996

21027

SPAT1088

SPAT

Blood transfusion

5.7

8.4

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.8

8.4

K70

ICD-10 Finland

Alcoholic liver disease

90.4

8.4

B01AB10

ATC

tinzaparin; parenteral

1.8

8.4

147

848

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

8.4

324

2294

ZZA00

NOMESCO Finland

Split skin graft

2.3

8.4

327

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.0

8.4

150

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.4

8.4

112

D02AE01

ATC

carbamide; topical

1.8

8.4

136

768

RS122

NOMESCO Finland

12.8

8.4

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

6.7

8.4

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

8.4

464

3524

A07AA02

ATC

nystatin; oral

1.8

8.3

145

838

JCA35

NOMESCO Finland

Endoscopic contact coagulation in oesophagus

+∞

8.3

R16.2

ICD-10 Finland

Hepatomegaly with splenomegaly, not elsewhere classified

+∞

8.3

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.3

8.3

342

M10.0

ICD-10 Finland

Idiopathic gout

2.3

8.3

330

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

8.3

291

Z94.1

ICD-10 Finland

Heart transplant status

10.8

8.3

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

9.5

8.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

8.2

175

1074

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

8.2

465

3543

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.7

8.2

198

A10BJ01

ATC

exenatide; parenteral

4.2

8.2

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.7

8.2

206

J01DA01

ATC

[U] cefalexin; systemic

1.3

8.1

1329

11795

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

8.1

419

S18

ICPC

Laceration/cut

1.3

8.1

905

7637

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.0

8.1

148

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.1

8.1

432

D23

ICPC

Hepatomegaly

33.5

8.1

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

17.2

8.1

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.7

8.1

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

11.7

8.1

S76

ICPC

Skin infection other

1.9

8.1

108

568

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

8.0

133

754

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.1

8.0

462

A10AE06

ATC

insulin degludec; parenteral

2.5

8.0

255

C08CA02

ATC

felodipine; oral

1.6

8.0

206

1329

K81.9

ICD-10 Finland

Cholecystitis, unspecified

3.8

8.0

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

8.0

172

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

8.0

212

1379

UJD10

SPAT

3.4

8.0

111

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.1

8.0

133

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

8.0

139

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

7.9

134

768

A10BB07

ATC

glipizide; oral

3.1

7.9

134

EBA00

NOMESCO Finland

Extraction of tooth

1.3

7.9

638

5143

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

13.1

7.9

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

7.8

7.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

7.9

1014

8714

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

7.8

610

4890

SPAT1263

SPAT

Sampling

1.3

7.8

869

7320

A04

ICPC

Weakness/tiredness general

1.5

7.8

241

1625

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

7.8

351

2563

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.3

7.8

294

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.7

7.8

187

K86.2

ICD-10 Finland

Cyst of pancreas

4.0

7.8

R77.0

ICD-10 Finland

Abnormality of albumin

15.1

7.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

7.7

338

2457

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

5.6

7.7

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.8

7.6

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.6

375

2786

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

7.6

154

933

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

7.6

233

A10BX01

ATC

guar gum; systemic

2.1

7.6

413

K76.80

ICD-10 Finland

Hepatic cyst

18.4

7.6

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.9

7.6

144

474

NOMESCO Finland

25.1

7.6

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

25.1

7.6

WX110

NOMESCO Finland

Local anesthesy

1.3

7.6

1409

12660

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

7.5

125

712

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.8

7.5

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.5

503

3940

H3601, E113

ICD-10 Finland

2.9

7.5

149

A10BG02

ATC

rosiglitazone; oral

3.0

7.5

140

A02BC03

ATC

lansoprazole; oral

1.3

7.5

613

4947

4560A

ICD-9 Finland

Varicose veins of other sites, Oesophageal varices with bleeding

80.3

7.4

JL5AM

NOMESCO Finland

Bile and pancreas ducts simple MRI examination with 3 Tesla magnet

80.3

7.4

H26.3

ICD-10 Finland

Drug-induced cataract

5.0

7.4

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.8

7.4

164

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

13.4

7.4

176

Kela drug reimbursment

Regorafenib

13.4

7.4

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.0

7.4

482

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

3.6

7.4

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

3.9

7.4

S29

ICPC

Skin symptom/complaint other

1.4

7.3

336

2461

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

7.3

127

733

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

7.3

460

E000003

ATC

2.0

7.3

460

L01BB02

ATC

mercaptopurine; oral

4.3

7.3

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

8.4

7.3

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

7.3

169

1063

K76.5

ICD-10 Finland

Hepatic veno-occlusive disease

+∞

7.3

6615

FHL

Liver transplant

+∞

7.3

57308

ICD-8 Finland

Other diseases of liver, Alii definiti

+∞

7.3

K71.2

ICD-10 Finland

Toxic liver disease with acute hepatitis

+∞

7.3

A02BC05

ATC

esomeprazole; systemic

1.3

7.3

848

7175

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

9.4

7.3

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

9.4

7.3

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

4.9

7.3

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.2

7.2

115

I50.1

ICD-10 Finland

Left ventricular failure

1.9

7.2

102

551

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

7.2

282

2000

602

Kela drug reimbursment

Children's severe malnutrition

15.8

7.2

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.6

7.2

185

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

7.2

122

699

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.4

7.2

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

7.2

203

1341

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

3.3

7.2

105

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

7.2

116

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.9

7.2

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.7

7.2

RS321

NOMESCO Finland

20.1

7.1

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.2

7.1

335

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

7.1

253

3462

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

12.1

7.1

J01AA02

ATC

doxycycline; systemic

1.3

7.1

1722

15922

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

3.6

7.1

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

6.0

7.1

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

6.0

7.1

K85

ICD-10 Finland

Acute pancreatitis

2.6

7.1

181

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.7

7.0

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

7.0

499

XF622

NOMESCO Finland

Measurement of minute volume of heart

7.0

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.0

7.0

124

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

7.0

244

1695

A03

ICPC

Fever

1.5

6.9

255

1787

2BD01

NOMESCO Finland

7.5

6.9

D61.9

ICD-10 Finland

Aplastic anaemia, unspecified

13.8

6.9

D07AC13

ATC

mometasone; topical

1.3

6.9

580

4690

L76

ICPC

Fracture: other

2.3

6.9

273

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

2.1

6.8

353

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

4.8

6.8

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

6.7

6.8

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.5

6.8

208

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

6.8

460

R06AE07

ATC

cetirizine; oral

1.3

6.8

834

7088

M81.4

ICD-10 Finland

Drug-induced osteoporosis

6.1

6.8

3019

Kela drug reimbursment

Lenvatinib

40.2

6.8

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

40.2

6.8

L01EX02

ATC

sorafenib; oral

40.2

6.8

L17

ICPC

Foot/toe symptom/complaint

1.3

6.7

501

3978

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

6.7

113

648

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.4

6.7

N05AA02

ATC

levomepromazine; systemic

2.0

6.7

429

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.2

6.6

305

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.1

6.6

112

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.4

6.6

224

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.2

6.6

306

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

6.6

160

1017

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

6.6

718

6002

N05CF02

ATC

zolpidem; oral

1.4

6.6

335

2501

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

3.9

6.6

130

Kela drug reimbursment

Malignant tumour

1.6

6.6

172

1116

F60.2

ICD-10 Finland

Dissocial personality disorder

8.7

6.5

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

6.5

312

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

6.5

453

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

10.0

6.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

6.5

322

2391

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.5

6.5

200

K80

ICD-10 Finland

Cholelithiasis

3.2

6.5

SPAT1216

SPAT

Assessment of functional ability

1.4

6.5

324

2411

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

5.7

6.4

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.9

6.4

120

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

6.4

163

1048

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

70.0

6.4

5761A

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]

70.0

6.4

SPAT1281

SPAT

Other administrative function

1.6

6.4

155

986

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

7.4

6.4

XX4BW

NOMESCO Finland

7.4

6.4

S20

ICPC

Corn/callosity

2.4

6.4

204

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

14.3

6.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.6

6.4

K02.1

ICD-10 Finland

Caries of dentine

1.2

6.4

1087

9585

N02AC04

ATC

dextropropoxyphene; oral

1.9

6.3

453

N05AB01

ATC

dixyrazine; systemic

3.0

6.3

116

C07AB03

ATC

atenolol; systemic

1.7

6.3

128

776

5BA08

NOMESCO Finland

5.2

6.3

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.2

6.3

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

6.0

6.3

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

6.3

116

686

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

6.3

536

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.3

6.3

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

6.3

57100

ICD-8 Finland

Cirrhosis of liver, Cirrhosis cum alcoholismo

+∞

6.3

TJA00

NOMESCO Finland

Puncture of peritoneum

26.7

6.2

I78.8

ICD-10 Finland

Other diseases of capillaries

7.0

6.2

H03AA01

ATC

levothyroxine sodium; systemic

1.3

6.2

457

3620

RS221

NOMESCO Finland

2.7

6.2

141

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.5

6.2

I73.0

ICD-10 Finland

Raynaud syndrome

2.8

6.2

128

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.8

6.2

128

318

Kela drug reimbursment

Teriparatide

5.0

6.2

P01BA02

ATC

hydroxychloroquine; oral

1.6

6.2

165

1079

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

6.2

500

SPC35

NOMESCO Finland

Production and attachment of single tooth bridge

2.8

6.2

135

N06AX03

ATC

mianserin; oral

1.8

6.2

547

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.5

6.2

H05AA02

ATC

teriparatide; parenteral

5.3

6.1

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

6.1

345

2620

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.9

6.1

113

H36.01

ICD-10 Finland

Diabetic maculopathy

2.9

6.1

113

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.5

6.1

185

N05BA12

ATC

alprazolam; oral

1.5

6.1

198

1352

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

6.1

408

3187

J01CF05

ATC

flucloxacillin; systemic

1.9

6.1

417

K51

ICD-10 Finland

Ulcerative colitis

4.0

6.1

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

12.5

6.1

K77

ICPC

Heart failure

2.4

6.0

198

P19

ICPC

Drug abuse

4.9

6.0

K29.2

ICD-10 Finland

Alcoholic gastritis

6.7

6.0

D07XC01

ATC

betamethasone, combinations; topical

1.5

6.0

231

1634

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.0

6.0

109

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3033658) Prothrombin time (PT) actual/Normal

1492

5863

4.40

321.76

14.1

3.7

78.1

88.9

35.27

1448

5726

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

178

63.39

321.61

3.7

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

405

485

9.63

320.23

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

827

2117

5.16

310.64

13.0

7.2

mmol/l

11.4

10.0

5.01

804

2012

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

315

276

12.77

310.05

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

211

28.14

309.15

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

211

28.14

309.15

1.1

1.0

—

(3033799) Differential panel - Peritoneal fluid

291

87.89

307.65

2.5

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

874

224

56.85

307.65

3.6

2.0

u/ml

1475.2

183.5

0.63

860

216

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

469

101

55.83

307.65

1.4

1.2

titre

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

969

2233

6.17

307.65

2.4

1.7

1.6

1.5

5.15

808

1941

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1295

3265

6.63

307.65

3.3

2.5

g/l

2.3

0.96

1210

3035

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1196

2103

9.32

307.65

1.6

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

224

29.30

307.65

1.1

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1325

3850

5.73

307.65

1.8

1.5

g/l

4.0

2.4

60.82

1133

2239

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

295

135

24.37

307.65

1.3

1.2

titre

212.5

69.6

2.03

(40768441) Liver Pathology biopsy report

497

65.08

307.65

2.0

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

882

377

34.04

307.65

5.9

1.7

umol/l

44.6

32.3

11.60

806

315

(3017143) Hepatitis C virus Ab [Presence] in Serum

1145

1903

9.63

307.65

1.6

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

399

49.00

307.65

1.1

1.0

mg/l

290.6

293.5

0.13

352

(3034770) Mitochondria Ab [Titer] in Serum

1178

364

56.06

307.65

1.4

1.1

titre

1159.7

732.9

—

175

(3028026) IgM [Mass/volume] in Serum or Plasma

1270

1126

20.18

307.65

1.8

1.9

g/l

1.9

1.4

4.87

1167

1026

(3007566) Smooth muscle Ab [Titer] in Serum

1173

361

56.11

307.65

1.4

1.1

titre

93.9

106.3

0.22

101

(3044007) Cell count panel - Peritoneal fluid

237

63.19

307.65

2.5

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2327

12026

7.24

307.65

19.5

6.0

umol/l

20.0

11.3

41.03

2298

11408

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

277

73.27

307.65

2.5

1.5

e6/l

12186.9

4181.2

0.57

157

(3037522) Nuclear Ab [Titer] in Serum

1301

2687

8.32

307.65

1.6

1.3

titre

875.3

549.2

4.41

380

554

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1205

2455

7.98

307.65

8.1

2.5

umol/l

13.8

7.8

10.81

1117

2161

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1662

2024

19.36

307.65

5.2

1.9

g/l

0.2

57.09

1531

1895

(3026692) Albumin [Mass/volume] in Peritoneal fluid

263

90.82

307.65

1.7

1.1

g/l

10.6

16.5

2.81

190

(3016650) Hepatitis A virus Ab [Presence] in Serum

326

257

14.26

307.65

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

604

192

40.08

307.65

1.2

1.1

g/l

1.6

1.5

3.80

545

178

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1292

3043

7.15

307.65

3.3

2.6

24.1

22.3

2.57

1140

2603

(3022948) Iron [Moles/volume] in Serum or Plasma

1329

3557

6.32

307.65

3.3

2.5

umol/l

13.0

12.7

0.45

1261

3303

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1961

7044

7.29

307.65

10.1

3.0

u/l

46.8

34.1

13.06

1909

6686

(3024561) Albumin [Mass/volume] in Serum or Plasma

2260

10047

8.17

307.65

13.5

4.6

g/l

33.1

35.3

59.37

2212

9330

(3005719) IgG [Mass/volume] in Serum or Plasma

1348

1467

17.14

307.65

2.6

2.9

g/l

13.3

10.3

52.92

1255

1343

(3023487) Leukocytes [#/volume] in Peritoneal fluid

305

79.70

307.65

2.7

1.8

e6/l

397.0

1089.4

1.56

216

(44816559) Phosphatidylethanol [Mass/volume] in Blood

415

303

15.97

307.65

1.9

1.2

—

(3032080) INR in Blood by Coagulation assay

1962

9646

4.65

304.21

18.3

9.5

inr

1.3

0.63

583

2685

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

493

849

6.86

282.95

3.4

u/ml

54.1

5050.2

0.91

428

728

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

189

25.95

269.43

4.1

1.9

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

581

1280

5.49

256.23

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

307

345

9.90

253.39

1.4

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

942

3102

4.11

248.79

8.7

5.8

mmol/l

1.1

1.0

6.14

894

2861

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1528

7166

3.56

232.50

4.7

2.4

u/l

58.2

58.7

0.15

1455

6610

(4281824)

236

209

12.26

229.60

1.4

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1748

9029

3.59

225.45

4.7

2.8

ug/l

172.8

139.0

3.89

1662

8294

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1315

5793

3.44

217.73

3.5

2.2

mg/l

3.7

3.0

14.72

1206

4916

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1017

3839

3.62

214.93

5.3

3.3

mmol/l

0.8

18.77

967

3576

(3026250) Tacrolimus [Mass/volume] in Blood

161

21.59

213.84

35.4

30.8

ug/l

7.2

7.3

0.16

144

(3018677) aPTT in Platelet poor plasma by Coagulation assay

978

3638

3.63

210.81

3.1

2.0

31.9

29.8

17.26

942

3536

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

274

341

8.82

208.08

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

265

319

9.09

206.65

1.4

1.2

u/ml

348.0

261.6

2.51

157

190

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

227

223

11.01

205.75

1.3

1.1

u/l

47.0

55.3

1.44

161

157

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

295

410

7.94

204.18

8.4

5.0

iu/ml

785.2

694.8

0.09

(3042936) Bacteria identified in Isolate by Culture

913

3320

3.63

202.69

3.1

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

349

608

6.43

195.48

5.4

3.4

mg/l

1.8

1.6

3.93

331

555

(3024980) IgG subclass 4 [Mass/volume] in Serum

247

297

9.04

192.55

1.7

g/l

0.8

0.19

206

222

(40768797) Stomach Pathology biopsy report

876

3196

3.56

192.10

1.4

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

789

2696

3.71

191.27

3.3

4.3

u/l

240.4

244.2

0.31

760

2557

(42870588) Differential panel, method unspecified - Blood

1519

7712

3.18

191.00

9.4

5.8

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

274

380

7.90

189.72

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

132

26.12

189.51

1.8

5.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

251

318

8.59

187.53

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

751

2519

3.73

186.73

3.6

4.2

ug/l

4.8

25.1

4.16

636

2074

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

271

379

7.83

186.21

1.4

u/ml

25.5

18.7

—

(3006315) Basophils [#/volume] in Blood

1912

11212

3.34

184.74

10.0

5.7

e9/l

0.0

0.59

1717

9621

(3001604) Monocytes [#/volume] in Blood

1906

11160

3.33

184.55

10.0

5.7

e9/l

0.6

0.92

1707

9569

(3022096) Basophils/100 leukocytes in Blood

1792

10165

3.21

182.47

10.6

6.0

0.7

2.81

1727

9447

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2203

14164

3.85

181.18

11.7

2.9

u/l

155.6

48.5

111.99

2132

13060

(3019069) Monocytes/100 leukocytes in Blood

1825

10503

3.21

180.32

10.9

6.3

9.5

8.8

13.58

1761

9785

(3010375) cycloSPORINE [Mass/volume] in Blood

148

17.52

178.83

33.0

25.7

ug/l

123.1

117.2

0.30

125

(3006504) Eosinophils/100 leukocytes in Blood

1817

10462

3.19

178.74

10.6

5.9

3.1

2.9

3.08

1751

9703

(3019198) Lymphocytes [#/volume] in Blood

1923

11450

3.28

178.13

10.1

5.8

e9/l

1.7

1.9

3.61

1738

10012

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

178

151

12.54

177.44

1.1

1.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

249

336

8.05

176.29

1.4

u/ml

142.8

124.5

0.33

(3013115) Eosinophils [#/volume] in Blood

1932

11594

3.27

175.30

10.4

6.0

e9/l

0.2

0.64

1746

10106

(3048929) Epstein Barr virus Ab [Presence] in Serum

297

495

6.61

173.27

1.4

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

1835

10750

3.15

172.54

10.8

6.1

25.9

27.4

7.35

1761

9953

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

343

662

5.78

172.13

2.2

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1928

11699

3.19

168.61

12.7

6.8

mmol/l

1.2

16.48

1677

9858

(3027945) Reticulocytes/100 erythrocytes in Blood

758

2740

3.44

165.70

3.2

2.5

2.2

1.8

14.45

692

2429

(3018010) Neutrophils/100 leukocytes in Blood

1800

10592

3.04

164.73

10.4

5.9

58.1

57.5

1.44

1732

9856

(3024471) HLA-A [Type]

121

22.16

163.12

1.0

—

(3024932) HLA-DR beta [Type]

120

22.37

162.40

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1016

4416

3.07

162.15

1.4

1.2

u/ml

1.7

1.4

0.26

220

1182

(3022217) INR in Platelet poor plasma by Coagulation assay

819

3171

3.26

159.22

19.5

26.5

inr

1.3

1.4

0.42

126

424

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

431

1080

4.55

158.85

2.0

1.8

g/l

1.1

1.6

19.09

364

939

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

324

638

5.63

158.73

4.3

2.3

g/l

2.8

3.7

18.70

318

606

(3002032) Base excess in Venous blood by calculation

641

2176

3.54

153.58

6.2

3.6

mmol/l

1.1

2.0

5.21

507

1752

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1788

10724

2.92

153.36

10.9

6.1

mmol/l

1.2

16.93

1704

9679

(3021447) Carbon dioxide [Partial pressure] in Venous blood

642

2184

3.53

153.29

6.2

3.6

kpa

5.6

5.8

9.15

624

2112

(3023368) Bacteria identified in Blood by Culture

1281

6502

2.82

150.98

6.6

4.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

425

1103

4.38

149.26

5.6

4.0

mmol/l

23.2

24.1

5.06

400

989

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

622

2111

3.52

148.66

4.1

2.3

u/l

31.9

40.0

2.09

563

1817

(3013650) Neutrophils [#/volume] in Blood by Automated count

2016

13129

3.03

143.91

13.3

9.0

e9/l

3.8

4.1

5.71

1850

11420

(3018418) pH of Serum or Plasma

1321

6942

2.75

143.56

6.2

4.1

7.4

0.15

283

1319

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

271

511

5.78

138.67

3.0

3.4

u/ml

165.0

856.1

0.75

248

473

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

108

19.68

138.50

1.8

1.6

iu/ml

796071.4

2090600.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

143

129

11.64

136.70

1.4

1.1

u/l

142.3

73.8

5.12

131

112

(3000991) Gas panel - Venous blood

581

1996

3.43

135.16

12.3

8.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

211

321

7.04

133.66

2.8

u/ml

895.8

2077.5

0.43

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

139

125

11.66

133.13

1.4

1.1

u/l

33.2

14.2

2.78

126

107

(3023520) Reticulocytes [#/volume] in Blood

586

2045

3.37

132.73

3.4

2.6

e9/l

80.4

69.6

6.38

444

1564

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

142

137

10.88

129.69

1.8

1.5

u/l

8.1

6.0

0.36

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

159

181

9.26

128.73

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

160

189

8.93

125.83

2.4

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

127

113

11.74

122.41

3.8

2.1

umol/l

30.8

6.3

7.08

113

(3044640) Blood type and Crossmatch panel - Blood

1305

7314

2.50

117.38

4.3

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

661

2654

2.97

116.34

1.8

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

550

1993

3.20

115.81

1.9

2.8

g/l

66.8

66.3

0.62

509

1815

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1532

9281

2.48

115.53

3.8

2.2

nmol/l

74.8

78.3

5.12

1453

8234

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2369

17825

3.45

113.58

24.2

7.3

u/l

126.8

78.1

146.58

2338

16769

(3014576) Chloride [Moles/volume] in Serum or Plasma

715

3037

2.83

113.00

10.3

6.8

mmol/l

104.3

104.4

0.27

700

2969

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

487

1675

3.32

111.53

2.1

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

286

679

4.59

111.48

3.1

2.2

67.0

90.6

28.98

280

647

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

253

569

4.80

105.29

1.7

1.3

iu/ml

6.6

18.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

120

131

9.53

100.10

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

329

937

3.85

100.10

1.4

1.5

u/ml

12.4

24.0

0.52

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

105

11.10

97.90

1.9

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

283

738

4.16

97.26

1.7

1.6

titre

106.0

387.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1035

5651

2.34

93.38

4.1

2.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

253

626

4.35

93.13

3.3

2.4

221.0

195.6

3.65

245

601

(3014111) Lactate [Moles/volume] in Serum or Plasma

530

2107

2.88

93.11

10.3

7.0

mmol/l

1.8

1.3

8.31

510

2024

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

236

555

4.56

92.71

1.8

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

15.15

91.51

1.7

1.4

ug/l

10.9

8.2

3.57

(3013826) Glucose [Moles/volume] in Serum or Plasma

1927

13697

2.37

90.96

11.0

4.7

mmol/l

7.6

6.8

25.86

1861

12895

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

15.30

86.38

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

14.64

85.44

1.1

1.0

—

(3026782) Osmolality of Urine

865

4534

2.33

84.20

3.6

2.8

mosm/kgh2o

517.5

551.1

4.82

770

3864

(3036489) Thrombin time

283

836

3.66

81.08

3.0

2.0

24.2

21.4

6.54

267

750

(3016502) Oxygen saturation in Arterial blood

569

2525

2.58

79.46

11.2

7.7

95.7

95.6

0.13

547

2437

(3027801) Oxygen [Partial pressure] in Arterial blood

613

2825

2.51

79.00

10.8

7.3

kpa

11.7

12.2

1.84

587

2696

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

613

2825

2.51

79.00

10.8

7.3

kpa

4.8

5.1

9.86

587

2698

(3019309) Folate [Moles/volume] in Red Blood Cells

840

4448

2.28

78.96

2.0

1.8

nmol/l

1217.6

1174.4

0.59

680

3328

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

33.93

78.35

1.2

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

426

1668

2.84

75.93

1.7

2.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

445

1797

2.76

74.71

5.3

3.0

kpa

4.8

4.6

1.15

422

1732

(3002582) Erythrocytes [#/volume] in Urine

1151

7025

2.10

74.52

4.4

3.2

e6/l

146.5

76.8

0.34

935

5418

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

755

3904

2.29

74.44

2.2

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1051

6202

2.13

74.37

4.1

2.7

umol/l

3749.3

5305.0

0.56

931

5340

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1569

10756

2.07

73.82

7.0

4.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

273

837

3.51

73.72

3.5

3.0

u/ml

0.3

5.09

159

477

(3003396) Base excess in Arterial blood by calculation

600

2819

2.45

73.61

10.9

7.3

mmol/l

-0.1

1.2

8.10

480

2214

(3009343) pH of Capillary blood

391

1504

2.87

71.82

5.2

3.6

7.4

0.42

187

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

721

3713

2.28

71.37

3.5

2.9

e6/l

2.9

2.1

1.40

431

2022

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

380

1448

2.89

70.99

5.1

3.6

mmol/l

0.8

1.9

4.12

265

1068

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

392

1525

2.83

70.43

5.2

3.6

kpa

4.8

5.2

10.27

374

1402

(3002173) Hemoglobin [Mass/volume] in Arterial blood

518

2328

2.51

69.62

12.0

8.1

g/l

111.2

121.6

21.20

499

2247

(3030467) Casts [#/volume] in Urine by Automated count

1066

6448

2.07

69.49

4.2

3.1

e6/l

0.6

0.4

2.00

858

4877

(3017181) Myelocytes/100 leukocytes in Blood

452

1911

2.64

68.94

5.3

4.1

0.6

0.9

1.25

168

562

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1433

9706

2.00

67.34

2.4

2.0

pmol/l

94.2

0.01

793

4979

(3021589) Normoblasts [#/volume] in Blood

1460

9956

2.00

67.26

19.2

9.7

e9/l

0.0

0.22

1248

8134

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

345

1285

2.93

67.02

12.8

9.5

mmol/l

23.5

24.4

4.63

326

1204

(3002179) Metamyelocytes/100 leukocytes in Blood

417

1728

2.67

66.04

5.0

3.9

0.5

0.6

0.47

118

398

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

346

1308

2.88

65.34

13.2

10.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

231

689

3.57

64.87

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

275

916

3.23

64.80

2.2

1.8

u/l

48.2

38.5

6.24

247

800

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

115

7.97

64.79

1.1

1.0

u/l

122.2

72.1

4.94

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

116

7.90

64.32

1.1

1.0

u/l

35.5

22.1

1.57

(3018095) Leukocytes [#/volume] in Urine

1241

8122

1.97

63.06

5.1

3.7

e6/l

92.8

105.9

0.30

968

5820

(4035726)

464

2072

2.49

62.72

1.7

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

424

1816

2.58

62.58

5.4

3.9

ng/l

103.0

91.5

1.21

384

1557

(40758558) Short blood count panel - Blood

968

5849

2.01

61.58

9.7

6.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

217

644

3.57

61.34

1.8

1.7

—

(36304419) Bacteria [Presence] in Urine

1015

6258

1.99

60.78

4.2

3.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

109

191

5.90

59.68

1.2

1.5

g/l

9.9

6.6

4.47

130

(3024139) IgG subclass 3 [Mass/volume] in Serum

109

191

5.90

59.68

1.2

1.5

g/l

0.8

0.4

2.21

130

(3028192) IgG subclass 2 [Mass/volume] in Serum

109

191

5.90

59.68

1.2

1.5

g/l

3.2

3.0

0.77

130

(3021440) Promyelocytes/100 leukocytes in Blood

417

1814

2.53

59.39

5.4

4.1

0.1

1.88

159

517

(4062490)

109

194

5.81

58.72

1.2

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

925

5585

1.99

58.30

1.9

1.6

nmol/l

18.8

20.7

3.39

851

4745

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

717

3981

2.09

56.81

3.3

2.7

e6/l

1.8

1.1

0.78

426

2275

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

543

2721

2.24

55.84

2.0

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1157

7617

1.90

55.73

4.7

4.0

mg/mmol

17.2

8.0

4.51

825

4789

(3025159) Blasts/100 leukocytes in Blood

391

1699

2.52

55.61

5.4

4.2

0.5

0.3

0.16

131

436

(3013707) Erythrocyte sedimentation rate by Westergren method

2097

16830

2.05

54.11

7.4

4.1

mm/h

24.6

12.6

112.48

1993

15534

(3009508) Creatinine [Moles/volume] in Urine

1137

7498

1.88

54.01

4.1

3.1

mmol/l

6.8

7.5

5.47

961

6266

(3007853) Bacteria identified in Skin by Aerobe culture

527

2645

2.23

53.80

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

536

2715

2.21

53.46

2.1

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

806

4755

1.99

53.43

7.0

4.5

—

(3026008) Bacteria identified in Urine by Culture

1068

6923

1.89

53.35

4.0

3.3

—

(3000850) Epithelial cells [#/volume] in Urine

825

4922

1.97

52.84

3.4

2.6

e6/l

6.4

5.2

1.33

743

4307

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

107

207

5.34

52.67

2.0

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

195

600

3.42

52.00

1.5

g/l

0.2

5.24

181

571

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

362

1564

2.51

51.93

13.8

8.9

0.6

0.7

1.38

362

1552

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

362

1572

2.50

51.34

13.7

8.8

1.5

1.3

2.15

362

1562

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

191

593

3.39

50.19

1.3

1.2

u/ml

34.9

41.6

0.16

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

197

625

3.32

50.00

1.5

g/l

1.2

0.48

184

594

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

160

443

3.77

50.00

1.3

1.2

u/ml

20.9

5.4

0.53

(3012516) Albumin [Mass/volume] in Urine

1092

7248

1.84

49.69

3.8

3.2

mg/l

462.4

273.7

0.72

785

4574

(3036481) Cortisol [Moles/volume] in Serum or Plasma

427

2029

2.31

49.38

2.1

2.2

nmol/l

362.6

372.3

0.29

404

1856

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

182

554

3.45

49.32

1.4

1.2

u/ml

33.3

3.8

1.03

(3000093) Morphology [Interpretation] in Blood Narrative

106

218

5.02

48.68

1.2

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

182

561

3.40

48.35

1.4

1.2

u/ml

6.4

8.2

0.18

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

218

757

3.04

47.51

1.6

3.6

ratio

1.9

2.4

0.21

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

943

2.83

47.44

1.6

2.6

g/l

7.2

7.4

0.87

175

721

(3022313) Gas panel - Capillary blood

278

1104

2.69

47.22

5.6

3.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

250

943

2.82

46.88

1.6

2.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

221

781

2.99

46.69

1.7

3.7

mg/l

59.5

70.7

0.24

180

640

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

249

943

2.80

46.33

1.6

2.6

g/l

4.4

3.8

6.05

170

689

(3034860) Kappa light chains.free [Mass/volume] in Serum

220

780

2.98

46.20

1.7

3.7

mg/l

70.8

62.2

0.35

179

638

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1065

7138

1.81

45.99

3.9

3.0

ng/l

2135.0

1427.4

2.83

956

6132

(40760888) Immunoglobulin light chains.free panel - Serum

181

583

3.25

44.76

1.6

3.8

—

(3003181) Sodium [Moles/volume] in Urine

146

414

3.67

44.02

1.4

mmol/l

51.1

62.0

2.50

104

335

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

478

2484

2.12

43.91

4.3

3.5

—

(3037756) Immunofixation for Serum or Plasma

166

516

3.36

43.47

1.2

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

233

881

2.80

43.42

1.5

2.6

g/l

14.1

10.1

14.54

199

756

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

249

982

2.69

42.76

2.4

2.0

ug/l

1.6

2.2

0.50

223

869

(3031040) Bacteria [#/volume] in Urine by Automated count

1870

14933

1.80

42.62

6.1

4.6

e6/l

796.8

1860.1

0.88

231

(3015235) Bicarbonate [Moles/volume] in Capillary blood

181

609

3.11

41.58

3.6

3.2

mmol/l

23.3

24.9

3.90

163

525

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

143

420

3.54

40.89

1.3

1.2

u/ml

78.0

47.9

0.90

(3004119) Hemoglobin [Mass/volume] in Venous blood

320

1460

2.35

40.24

5.6

3.1

g/l

115.0

128.7

18.87

312

1423

(3039162) Centromere protein B Ab [Units/volume] in Serum

106

256

4.27

39.94

1.3

1.2

u/ml

96.1

56.4

0.88

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

226

884

2.70

39.37

1.6

2.7

g/l

3.1

0.03

176

706

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

769

4865

1.81

38.91

2.3

1.8

mg/l

2.3

1.2

6.99

666

3765

(3037467) Urinalysis macro (dipstick) panel - Urine

1911

15552

1.76

38.59

6.2

4.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

733

4621

1.80

37.27

4.5

3.8

ng/l

452.7

605.5

0.26

597

3751

(3042111) Morphology [Interpretation] in Bone marrow Narrative

137

416

3.41

37.20

1.6

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

145

5.29

36.94

1.5

1.3

promille

0.7

1.3

3.19

109

(1616796) Gas panel - Central venous blood

155

510

3.16

36.94

4.1

4.2

—

(3022145) Colonoscopy Study observation

468

2562

2.00

36.77

1.7

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

148

475

3.24

36.76

1.6

1.7

—

(36660697) Celiac disease serology panel - Serum

332

1596

2.23

36.75

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

310

1452

2.28

36.52

1.9

1.6

—

(3021901) Oxygen saturation in Capillary blood

139

434

3.32

36.11

3.2

2.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

116

5.81

36.01

2.3

1.8

—

(3004809) Band form neutrophils/100 leukocytes in Blood

128

382

3.47

35.70

3.3

3.6

1.1

1.5

0.66

298

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

299

1397

2.28

35.39

1.7

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

262

1158

2.40

35.24

6.2

3.1

mmol/l

24.3

25.3

3.04

252

1119

(3003434) Protein [Mass/volume] in Pleural fluid

116

328

3.65

35.11

1.8

1.5

g/l

27.9

32.5

2.72

105

292

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

373

1914

2.10

34.88

5.1

3.9

mmol/l

1.2

4.70

357

1664

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

142

462

3.19

34.48

1.3

1.2

—

11.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

154

527

3.04

34.31

1.5

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

438

2402

1.98

34.04

2.9

2.2

ug/g

177.2

144.1

1.09

369

1897

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

150

4.97

33.57

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

150

4.97

33.57

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

150

4.97

33.57

1.1

—

(3000494) Fungus identified in Specimen by Culture

479

2729

1.92

33.20

1.9

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

394

2105

2.02

32.90

4.0

2.9

ng/l

267.9

202.6

1.93

366

1921

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

153

4.87

32.80

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

153

4.87

32.80

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

153

4.87

32.80

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

184

723

2.66

31.67

1.5

2.5

g/l

0.0

0.20

162

668

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

201

828

2.54

31.42

2.8

2.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

221

952

2.44

31.39

6.3

3.8

mmol/l

23.6

24.9

6.58

207

881

(3024928) Oxygen saturation in Venous blood

144

499

2.99

31.37

4.0

3.0

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

199

818

2.55

31.24

1.6

2.7

g/l

0.8

1.1

0.43

171

715

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

756

5028

1.70

30.83

1.9

1.7

pmol/l

11610405.4

33373895.0

0.89

646

4153

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

110

330

3.43

30.44

8.0

6.7

mg/l

12.4

11.9

0.57

309

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

133

4.98

30.05

1.5

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

173

678

2.66

29.92

1.5

2.5

g/l

0.0

0.50

152

625

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

185

753

2.56

29.63

1.5

2.4

g/l

35.0

37.8

6.67

159

650

(3023199) Leukocytes [#/volume] in Pleural fluid

105

312

3.46

29.49

1.8

1.4

e6/l

1453.5

1651.6

0.27

228

(3012441) Differential panel - Pleural fluid

260

3.71

29.40

1.8

1.4

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

220

975

2.37

29.30

6.6

5.5

1.8

1.6

2.78

204

915

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

133

459

2.99

29.18

1.3

1.6

nmol/l

0.9

0.8

1.24

107

381

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

170

669

2.64

29.16

1.5

2.5

g/l

0.0

0.00

150

624

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

17.29

28.97

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.44

28.63

2.7

2.1

u/ml

44578.9

5417.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

137

486

2.91

28.62

1.6

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

131

4.90

28.59

1.5

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

216

963

2.35

28.36

6.8

5.5

0.9

0.48

202

906

(3000570) Elastase.pancreatic [Mass/mass] in Stool

168

670

2.61

28.04

1.4

ug/g

284.7

283.5

0.02

405

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

192

828

2.42

27.15

2.5

2.3

ug/l

1035.2

746.4

0.33

179

783

(3028308) Erythrocytes [#/volume] in Pleural fluid

276

3.49

26.90

1.8

1.4

e6/l

18050.4

92831.0

1.81

169

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

148

570

2.69

26.48

2.3

1.9

mg/l

12.7

12.1

0.28

141

520

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

986

7238

1.57

26.00

2.6

2.1

u/l

216.0

220.1

0.05

940

6781

(3015377) Calcium [Moles/volume] in Serum or Plasma

1069

8001

1.55

25.80

3.8

3.4

mmol/l

2.3

2.4

6.35

946

6962

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

228

1082

2.21

25.77

4.6

2.6

0.7

0.27

222

1040

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

349

1942

1.91

25.54

3.2

2.8

ml/min/173m2

58.0

64.5

1.57

153

777

(3019060) Gas panel - Arterial blood

306

1647

1.97

24.67

6.8

4.9

—

(3045788) Cell count panel - Pleural fluid

243

3.53

24.61

1.9

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

146

583

2.59

24.30

1.7

1.6

—

(40768806) Pleura Pathology biopsy report

269

3.35

23.68

1.8

1.5

—

(3037121) Protein [Mass/volume] in Urine

182

819

2.31

23.34

3.0

3.1

g/l

0.3

0.29

107

329

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

102

4.97

23.23

1.5

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

102

4.97

23.23

1.5

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

165

714

2.40

23.14

4.9

3.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

123

4.54

22.91

1.3

nmol/l

1.2

1.1

0.22

(3008152) Bicarbonate [Moles/volume] in Arterial blood

287

1556

1.94

22.59

10.1

7.0

mmol/l

23.8

24.6

2.51

265

1455

(3035350) Ketones [Presence] in Urine by Test strip

1360

10947

1.48

22.01

4.6

3.7

estimate

0.0

0.00

300

2005

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

137

560

2.52

21.73

1.7

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

115

431

2.74

21.71

4.2

3.4

56.0

57.5

0.59

115

431

(3008757) Leukocyte morphology finding [Identifier] in Blood

266

3.23

21.38

3.6

4.0

—

(40767503) Oxygen content in Capillary blood by calculation

126

501

2.59

21.17

3.3

2.6

14.7

16.2

3.42

253

(3012501) Base excess in Blood by calculation

130

525

2.55

21.15

5.5

4.9

mmol/l

2.2

2.6

0.73

366

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

113

426

2.72

21.10

1.6

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

1352

10966

1.46

20.46

6.3

5.0

estimate

0.0

0.50

303

2043

(3029075) Extractable nuclear Ab panel - Serum

5.97

20.42

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

15.09

20.21

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

287

3.06

20.06

1.5

1.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

+∞

19.81

1.1

0.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

279

3.07

19.75

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

279

3.07

19.75

1.5

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1361

11100

1.45

19.72

4.7

3.8

estimate

0.0

1.08

270

1966

(3005988) Vibrio sp identified in Specimen by Organism specific culture

281

3.05

19.52

1.5

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

240

3.23

19.45

3.3

3.6

62.2

57.1

0.88

153

(3013945) Hepatitis B virus e Ab [Presence] in Serum

15.54

19.36

1.3

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

123

4.21

19.33

1.9

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

123

4.21

19.33

1.9

1.6

—

(3035880) pH of Pleural fluid

136

4.03

19.33

1.4

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1149

9105

1.45

19.25

5.3

3.7

ng/l

50.2

106.4

0.60

908

6564

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

123

507

2.49

19.19

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

123

507

2.49

19.19

1.5

1.3

—

(3010421) pH of Blood

142

625

2.34

19.17

5.8

4.6

7.4

0.77

127

519

(3024522) Salmonella sp identified in Specimen by Organism specific culture

284

3.02

19.17

1.5

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

34.57

18.89

3.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

284

2.98

18.56

1.5

1.4

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.63

18.45

1.6

7.4

mg/l

57.2

71.1

0.77

(3047181) Lactate [Moles/volume] in Blood

158

742

2.20

18.29

7.9

6.7

mmol/l

1.7

1.3

1.21

136

655

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

6.31

18.01

1.1

—

(3016038) Potassium [Moles/volume] in Urine

148

3.77

17.98

1.1

1.2

mmol/l

35.2

33.7

0.17

128

(3025941) Bacteria identified in Stool by Culture

221

1188

1.94

17.75

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

122

520

2.41

17.72

2.8

2.2

g/l

117.6

130.1

4.75

378

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

338

2.75

17.52

1.6

—

(3044927) Protein electrophoresis panel - Urine

251

3.04

17.44

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

264

2.97

17.17

1.4

1.2

—

(3019225) pH of Specimen

379

2415

1.66

17.11

7.2

4.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

202

3.27

17.11

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

7.99

17.03

1.7

1.4

—

(21494434) Karyotype in Bone marrow

226

3.11

16.66

1.2

—

(3042631) Mycobacterium sp identified in Specimen

325

2.73

16.58

2.6

2.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

132

602

2.25

16.42

2.5

2.3

ug/min

90.7

98.6

0.11

379

(40768804) Tissue Pathology biopsy report

1141

9237

1.40

16.02

2.6

2.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

171

3.38

15.88

1.2

1.1

u/ml

26.4

4.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

7.24

15.68

1.4

1.8

18.7

4.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

226

3.01

15.41

3.6

2.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

251

2.88

15.03

1.4

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

102

434

2.40

14.91

1.1

1.3

miu/ml

205.4

203.4

0.02

180

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

134

641

2.15

14.84

1.7

1.6

iu/ml

0.1

10.9

0.57

124

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

179

3.23

14.79

1.2

1.1

u/ml

39.0

62.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.64

14.70

1.5

1.6

2.7

3.1

0.09

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

108

3.93

14.67

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

180

3.21

14.66

1.2

1.1

u/ml

76.0

37.7

0.83

(3038026) Centromere Ab [Units/volume] in Serum

186

3.16

14.54

1.3

1.1

u/ml

77.8

82.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

220

2.95

14.26

1.3

nmol/l

1.6

1.5

0.30

195

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

266

2.75

14.06

1.6

1.7

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.46

14.01

1.3

1.6

umol/l

95.2

117.1

—

(4198724)

5.44

14.00

9.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

151

774

2.01

13.92

1.7

1.6

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

7.65

13.56

1.1

1.2

u/l

13.2

24.3

0.80

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

169

911

1.91

13.46

2.2

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

181

1000

1.87

13.37

2.6

1.9

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.92

13.24

2.4

2.5

u/ml

2083.1

1293.1

0.43

(3000012) Reticulocyte production index

112

3.70

13.19

2.3

1.5

—

(3000492) Spirometry study

317

2057

1.61

13.16

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

210

1223

1.78

13.06

3.4

2.8

e6/l

0.3

0.08

205

1193

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

237

2.79

13.04

1.1

—

(3051651) Icteric interference index of Serum or Plasma

142

3.35

13.00

4.2

3.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

269

2.64

12.70

3.6

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

688

5280

1.40

12.51

4.0

3.7

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2392

22408

1.54

12.24

38.8

14.8

mg/l

19.8

24.8

20.75

2266

17863

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

3.88

12.08

1.5

62.7

60.3

0.13

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.29

12.01

1.9

1.8

—

(21494755) Public health laboratory ask at order entry panel

1532

0.41

11.99

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

4.43

11.90

1.7

1.6

—

(3003694) ABO and Rh group [Type] in Blood

748

5875

1.38

11.71

1.6

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

247

2.63

11.54

4.2

3.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

589

4459

1.41

11.45

3.3

3.0

mmol/l

2.5

10.93

506

3921

(44790048)

276

2.50

11.08

1.7

1.5

—

(44806118)

276

2.50

11.08

1.7

1.5

—

(44790049)

276

2.50

11.08

1.7

1.5

—

(44790047)

276

2.50

11.08

1.7

1.5

—

(3039000) Anion gap in Blood

109

540

2.06

11.08

9.4

7.6

mmol/l

11.2

11.3

0.03

487

(3018572) Chloride [Moles/volume] in Blood

109

540

2.06

11.08

9.4

7.6

mmol/l

105.1

105.4

0.25

487

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.28

11.01

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

418

2.19

10.81

1.6

1.5

—

(3002256) Pathology report gross observation

421

3034

1.46

10.66

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

727

5772

1.35

10.42

4.6

3.4

—

(3004775) Volume in Urine collected for unspecified duration

196

2.74

10.42

2.1

2.2

745.8

642.7

0.64

135

(3000919) Neutrophils/100 leukocytes in Pleural fluid

4.09

10.41

1.3

1.5

22.7

26.9

0.28

(40768443) Skin Pathology biopsy report

172

1014

1.74

10.28

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

107

544

2.01

10.16

1.3

1.2

—

(3013512) EKG study

865

7071

1.33

10.12

5.2

4.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1658

0.48

10.10

1.5

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.34

10.04

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

327

2.30

10.03

1.4

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

16.75

9.87

1.3

1.0

—

(3008295) Osmolality of Serum or Plasma

243

2.50

9.86

1.3

1.4

mosm/kgh2o

276.7

277.2

0.05

179

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

349

2.24

9.84

1.1

iu/ml

206.8

78.5

0.35

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

4.91

9.78

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

4.45

9.54

2.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

374

2.17

9.49

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

368

2.18

9.46

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

103

533

1.97

9.33

1.1

u/ml

4.6

4.2

—

(3028707) Methadone [Presence] in Urine by Screen method

169

2.75

9.19

7.7

1.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.52

9.07

1.4

1.3

—

(3045716) Anion gap in Serum or Plasma

111

3.18

9.04

2.2

2.5

mmol/l

8.5

9.8

1.13

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

336

2.20

9.02

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.74

8.80

1.5

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

366

2.14

8.79

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

180

2.64

8.69

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

104

3.20

8.63

2.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

5.03

8.61

2.0

2.8

mg/l

14.1

23.7

—

(3048879) Bone marrow aspiration report

3.74

8.61

1.2

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

501

1.95

8.51

3.5

3.2

nmol/l

0.8

0.13

388

(3045142) Bone marrow Pathology biopsy report

286

2.27

8.51

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

609

7530

0.75

8.40

3.9

3.0

—

(3017704) Immunofixation for Urine

149

2.78

8.39

1.3

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

549

6886

0.75

8.38

3.3

4.4

23.3

21.7

1.16

223

3448

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

190

2.55

8.32

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

375

4983

0.71

8.31

2.4

3.1

ug/l

0.7

0.8

0.25

259

3387

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

179

2.60

8.26

1.4

1.5

u/ml

28.3

26.1

0.11

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

246

2.35

8.22

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

266

2.28

8.14

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

190

2.50

7.82

1.5

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1072

0.44

7.79

1.4

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

194

1271

1.57

7.72

2.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

420

1.98

7.71

4.3

3.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

5.02

7.66

1.2

1.1

87.4

80.1

—

(40768446) Kidney Pathology biopsy report

3.32

7.51

1.4

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.08

7.43

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

114

2.92

7.43

2.5

—

(3014271) Vancomycin [Susceptibility]

125

2.82

7.43

3.9

2.9

—

(40761536) Microorganisms panel - Urine sediment

265

1871

1.46

7.40

4.9

4.1

—

(3036603) Volume of Urine

148

2.66

7.39

1.7

1.4

1930.3

1849.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

105

592

1.80

7.38

6.1

4.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

266

2.21

7.30

13.3

5.3

mmol/l

8.8

7.3

1.81

221

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.31

7.21

1.3

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

122

2.81

7.16

3.1

3.5

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.63

7.02

1.5

ug/l

0.4

0.24

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.21

6.97

1.1

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

4.46

6.70

1.8

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

298

2189

1.41

6.70

2.6

2.4

ug/l

9.5

7.1

0.58

262

1932

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

5.02

6.70

2.1

2.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.40

6.69

1.5

2.2

318.6

167.4

2.56

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.71

6.68

1.2

1.1

78.0

73.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

283

2.11

6.67

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

407

1.92

6.66

1.3

1.2

u/l

49.2

37.1

0.38

348

(3026389) Candida sp identified in Specimen by Organism specific culture

290

2.09

6.65

1.7

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

126

772

1.66

6.63

6.6

3.9

mmol/l

4.0

3.9

0.75

118

726

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

164

2.46

6.52

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

5.22

6.49

1.2

1.4

16.6

19.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.85

6.45

2.1

—

(3028433) Virus identified in Specimen by Culture

3.22

6.42

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

124

2.68

6.41

2.0

2.3

—

(3019977) pH of Arterial blood

130

2.64

6.39

3.4

2.8

7.4

0.62

(3016750) Collection duration of Urine

154

2.49

6.35

2.1

2.0

min

496.5

493.1

0.06

116

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

968

8401

1.24

6.27

5.2

4.0

—

(3020891) Body temperature

154

1006

1.56

6.25

8.4

4.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

126

2.64

6.22

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

126

2.64

6.22

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

126

2.64

6.22

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

126

2.64

6.22

1.7

—

(3011412) CD3 cells [#/volume] in Blood

212

2.24

6.20

1.6

2.3

e9/l

0.8

1.2

2.24

126

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

219

2.21

6.17

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

219

2.21

6.17

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

219

2.21

6.17

1.6

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

107

642

1.69

6.12

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

106

636

1.69

6.06

1.2

1.1

—

(3011648) Oxygen content in Venous blood

189

2.30

6.04

1.8

2.6

8.4

11.4

4.44

189

(42529406) Shigella sp [Presence] in Stool by Culture

107

647

1.68

5.95

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

112

2.70

5.92

3.5

4.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

154

2.42

5.87

2.2

2.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

298

2.00

5.85

7.5

1.5

—

(3047189) Immunofixation for 24 hour Urine

113

2.67

5.82

1.1

1.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.52

5.80

1.1

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

162

1090

1.52

5.77

2.3

3.7

u/ml

171.3

66.3

1.99

151

1052

(3043410) Blood group antigens tested for on Red Blood Cells

3.16

5.74

1.6

1.9

—

(3006653) Thiamine [Moles/volume] in Blood

120

2.60

5.71

1.3

1.2

nmol/l

126.2

138.2

0.76

120

(3008536) Aspergillus sp Ab [Presence] in Serum

3.55

5.60

1.3

1.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

320

1.93

5.45

1.5

1.2

u/ml

3.0

2.9

0.03

(3011288) Drugs identified in Urine by Screen method

258

2.04

5.44

11.2

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

314

1.93

5.41

1.6

1.3

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

161

2.32

5.35

1.3

1.2

—

(3000330) Specific gravity of Urine by Test strip

173

1201

1.47

5.32

5.0

3.4

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

3.48

5.17

1.5

1.2

mmol/l

1.3

1.8

1.12

(4146454)

259

1.99

5.03

2.9

2.6

—

(3002385) Erythrocyte distribution width [Ratio]

1946

18327

1.21

4.93

47.4

18.1

14.9

13.7

121.79

1933

17887

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

312

1.88

4.85

1.5

1.2

u/ml

4.0

5.1

0.30

135

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.17

4.76

7.6

7.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.17

4.76

1.3

77.1

91.9

0.72

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.95

4.71

12.0

13.5

mmol/l

4.4

5.5

1.44

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.12

4.63

1.3

1.1

81.3

90.0

0.57

(3027008) Opiates [Presence] in Urine

392

1.75

4.57

3.8

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.41

4.56

1.1

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

393

1.75

4.53

6.9

1.7

—

(3016879) Cocaine [Presence] in Urine

364

1.78

4.51

7.3

1.7

—

(3005322) IgE [Units/volume] in Serum or Plasma

175

1258

1.42

4.51

1.3

u/ml

243.0

212.3

0.30

158

1157

(3045424) Erythrocytes [Presence] in Urine

394

1.74

4.49

1.5

—

(3028300) Cannabinoids [Presence] in Urine

394

1.74

4.49

7.5

1.7

—

(4306422)

301

1.84

4.39

1.4

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.89

4.33

1.3

1.2

ug/l

13.3

509.2

—

(3026361) Erythrocytes [#/volume] in Blood

2408

24747

0.78

4.30

56.7

21.9

e12/l

4.1

4.5

129.37

2360

23996

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

101

2.49

4.29

1.9

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

2.17

4.27

1.4

1.6

—

(3035941) MCH [Entitic mass]

2408

24745

0.78

4.27

56.4

21.8

30.6

30.4

5.18

2387

24353

(3010813) Leukocytes [#/volume] in Blood

2409

24751

0.78

4.24

56.7

21.9

e9/l

6.6

6.7

1.34

2363

24002

(3029937) Albumin [Presence] in Urine by Test strip

691

5990

1.21

4.22

5.3

4.2

estimate

0.0

0.88

278

1955

(3000963) Hemoglobin [Mass/volume] in Blood

2410

24753

0.78

4.15

57.2

22.0

g/l

124.1

135.2

159.87

2392

24362

(3024731) MCV [Entitic volume]

2409

24743

0.78

4.14

56.5

21.8

92.4

91.3

18.02

2388

24354

(3027944) Amphetamines [Presence] in Urine

389

1.71

4.14

6.1

1.7

—

(3007461) Platelets [#/volume] in Blood

2409

24739

0.78

4.09

56.7

21.9

e9/l

200.6

248.1

124.68

2367

24075

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

3.09

4.08

2.4

8.4

53.8

76.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

891

0.56

4.07

1.5

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

170

2295

0.72

4.05

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.44

3.97

1.9

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.44

3.97

1.9

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

136

960

1.44

3.91

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

248

1.87

3.89

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.18

3.88

1.2

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.97

3.84

7.6

7.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

496

0.44

3.82

1.1

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

6.02

3.81

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

12.02

3.76

1.0

—

(3023419) Bacteria identified in Sputum by Culture

318

1.74

3.72

4.0

2.9

—

(3025315) Body weight

5.64

3.65

5.2

4.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

254

1.82

3.63

4.1

3.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.26

3.62

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

143

2.11

3.59

1.3

mmol/l

12.8

11.9

0.30

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.66

3.56

1.7

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

157

2.05

3.55

2.0

2.2

e6/l

612.4

643.9

0.09

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.45

3.55

1.2

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

164

2.02

3.54

1.6

2.3

13.5

12.6

0.11

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.86

3.52

1.0

1.3

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.86

3.52

1.0

1.3

mmol/l

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

10.02

3.49

1.0

—

(3017732) Neutrophils [#/volume] in Blood

199

1526

1.33

3.49

3.2

3.3

e9/l

3.9

4.1

0.71

144

1163

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.54

3.46

1.0

1.1

miu/ml

1604.4

1504.0

0.19

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1346

12495

1.15

3.35

2.9

2.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.93

3.30

1.0

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

768

8566

0.86

3.28

3.9

5.0

ug/l

2.2

3.5

1.35

676

7680

(4268621)

212

1.85

3.26

2.8

2.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

8.59

3.26

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

8.59

3.26

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

136

2.07

3.22

1.4

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

136

2.07

3.22

1.4

1.7

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.35

3.19

1.3

1.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1789

16978

1.16

3.19

4.3

4.0

pmol/l

14.8

14.9

0.65

1651

15312

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

303

1.70

3.18

1.3

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

207

1.85

3.17

1.3

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

647

1.47

3.14

1.4

1.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.01

3.05

1.0

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

133

2.04

3.01

3.1

2.8

36.8

37.6

0.07

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.15

2.93

2.6

1.4

ng/l

134.9

120.7

0.11

(3009214) Lutropin [Units/volume] in Serum or Plasma

445

1.54

2.91

1.5

1.3

u/l

12.7

10.5

0.40

355

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

108

2.14

2.90

1.1

ratio

1.1

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.68

2.87

2.2

4.4

—

(3042517) Benzodiazepines panel - Urine

6.68

2.87

4.2

1.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

144

1.95

2.80

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

325

1.61

2.72

2.0

1.6

—

(3045414) Leukocytes [Presence] in Urine

140

1062

1.34

2.71

2.1

1.9

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

146

1.93

2.70

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

112

2.06

2.67

1.5

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

228

1.72

2.63

1.7

—

1220.0

—

(4015189)

2.31

2.58

3.3

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.36

2.55

1.5

2.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2151

22158

0.86

2.53

5.7

4.6

mmol/l

1.4

1.5

19.96

2001

20276

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

432

3752

1.18

2.52

1.3

iu/ml

44.4

37.4

0.37

134

1196

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

270

1.64

2.50

1.8

u/l

5918.7

2456.7

0.24

104

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2119

20487

1.15

2.48

5.4

4.7

mu/l

2.2

2.1

0.52

1989

18574

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

279

1.62

2.46

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2169

22318

0.86

2.44

5.9

4.6

mmol/l

4.3

4.6

35.96

2036

20558

(44806420)

2.29

2.41

2.6

2.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2220

22794

0.86

2.37

6.2

5.2

mmol/l

2.4

2.7

41.62

2068

20879

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

349

2999

1.19

2.31

1.4

—

(3022621) pH of Urine by Test strip

188

1518

1.26

2.31

3.5

3.0

—

(40765096) Chromosome analysis panel by Banding

2.13

2.28

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.69

2.27

7.0

7.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

106

1.99

2.25

1.0

—

(3011985) Renin [Units/volume] in Plasma

287

1.58

2.22

1.6

1.4

mu/l

164.6

41.3

0.81

255

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.56

2.21

1.0

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.34

2.18

2.3

2.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.34

2.18

1.0

2.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.34

2.18

1.1

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.25

2.17

1.1

—

(1002224) Polysomnography panel

825

0.68

2.15

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

463

1.44

2.10

1.5

pmol/l

117.9

239.3

1.85

456

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.21

2.09

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

540

1.40

2.07

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.91

2.07

2.1

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

5.01

2.07

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.03

2.05

3.4

2.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.33

2.04

2.7

3.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

4.01

2.04

1.0

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2404

23546

1.17

2.01

45.0

17.2

mmol/l

138.3

139.7

84.54

2376

22969

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

140

1.79

2.00

2.3

2.1

ug/min

230.3

195.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.55

1.94

3.0

3.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.12

1.92

3.2

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.12

1.92

3.2

2.6

—

(3049717) Cytology report of Urine Cyto stain

122

961

1.28

1.88

2.6

—

(3051593) INR in Capillary blood by Coagulation assay

107

1.88

1.86

6.5

14.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

681

6241

1.12

1.83

1.9

1.7

mmol/l

1.5

1.4

2.38

611

5186

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.17

1.82

4.4

10.9

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.17

1.82

1.0

1.2

—

(3044941) Cell count panel - Synovial fluid

377

1.44

1.80

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

736

0.70

1.79

2.4

1.7

mg/l

5.4

3.9

0.63

527

(3025130) Human papilloma virus identified in Specimen

184

1.64

1.78

2.4

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2170

21148

1.13

1.77

9.8

6.0

mmol/mol

43.1

40.2

20.94

2059

19471

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

272

1.52

1.76

1.2

1.4

pmol/l

391.3

290.5

0.51

214

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.92

1.72

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

202

1.59

1.71

2.3

2.1

u/field

1.6

1.9

0.17

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.30

1.70

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

291

1.49

1.69

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.39

1.67

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

172

1.63

1.67

2.0

mmol/l

7.7

7.1

0.41

108

(3044889) 12 lead EKG panel

1704

16420

1.10

1.65

4.7

4.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

538

1.35

1.65

1.2

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2404

23605

1.15

1.65

45.2

17.4

mmol/l

4.0

1.46

2376

22992

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.25

1.63

2.2

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

1.82

1.63

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.15

1.61

1.1

—

(40757373) Influenza virus identified in Isolate

2.15

1.61

1.9

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

1.72

1.60

1.2

1.1

—

(4024509)

230

1.53

1.59

1.7

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.50

1.59

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

555

0.68

1.58

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

167

1.62

1.58

2.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

156

0.45

1.55

1.6

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.93

1.54

2.0

—

(3022689) Creatine [Moles/volume] in Urine

2.04

1.54

2.5

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.43

1.53

1.1

1.3

—

(4010399)

197

1678

1.19

1.51

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.86

1.50

1.3

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

259

1.47

1.48

1.0

1.1

u/ml

2.3

2.4

—

103

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.81

1.47

1.1

iu/ml

213.2

212.7

0.00

(3004451) EKG impression Narrative

124

1.70

1.47

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.50

1.45

1.1

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

228

1.50

1.44

5.2

3.0

mg/l

79.0

37.7

0.57

168

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.97

1.43

1.0

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

286

1.44

1.43

1.3

1.6

68.9

59.8

0.80

178

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.82

1.41

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.25

1.40

1.6

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

519

1.32

1.39

4.4

3.6

mg/l

28.2

27.1

0.07

315

(21494814) CD8 cells/100 lymphocytes in Specimen

1.78

1.39

1.8

2.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.08

1.38

5.0

2.3

mmol/l

9.3

8.2

—

(3021788) Differential panel - Synovial fluid

433

1.35

1.38

1.5

1.6

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.00

1.38

1.8

1.0

pmol/l

408.7

263.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

173

1473

1.19

1.36

1.2

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

270

3052

0.87

1.36

14.1

7.1

—

(40768793) Breast Pathology biopsy report

525

0.70

1.36

1.4

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

146

0.48

1.32

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

146

0.48

1.32

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.81

1.31

1.1

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.30

1.0

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

284

1.41

1.29

1.1

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

145

1.59

1.29

3.2

2.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.78

1.28

1.4

1.1

—

(40761535) Cells panel - Urine sediment

228

2004

1.15

1.22

4.3

3.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

117

972

1.21

1.22

1.7

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.04

1.22

1.2

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.63

1.21

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.17

1.21

1.1

1.5

pmol/l

36.8

46.8

—

(3019150) Specific gravity of Urine by Refractometry

524

4843

1.10

1.21

5.4

4.2

kg/l

1.0

0.30

103

711

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

145

0.48

1.19

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

145

0.48

1.19

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.31

1.18

1.0

1.5

nmol/l

0.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.31

1.18

2.0

2.8

u/field

1.0

0.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.16

0.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.50

1.15

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.81

1.15

4.8

2.0

ug/l

2.5

1.3

0.56

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.85

1.13

1.3

1.2

g/l

0.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

311

1.36

1.10

2.8

2.3

mg/l

23.0

22.9

0.01

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.73

1.09

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

128

1.57

1.08

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.93

1.06

1.1

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

113

1.60

1.05

1.3

1.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.12

1.05

1.0

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.27

1.03

1.8

1.3

u/l

9.0

15.6

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.00

1.00

1.0

1.2

—

(3024263) Appearance of Synovial fluid

131

1.53

0.99

1.8

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

656

1.23

0.99

1.3

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

223

1.39

0.98

1.5

25.7

31.3

0.33

138

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.2

—

22.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.97

0.0

1.2

—

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

1.85

0.96

1.4

2.3

e6/l

184.0

211.7

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

157

1.47

0.96

1.3

u/ml

1.4

0.00

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2109

21452

0.93

0.94

5.3

4.1

mmol/l

1.3

1.67

1961

19469

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

295

1.33

0.92

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

0.92

1.4

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

391

3617

1.09

0.91

1.3

1.2

u/ml

14.5

12.9

0.14

141

1375

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

147

1285

1.15

0.91

2.3

3.3

pmol/l

4.0

4.4

4.49

129

1128

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2176

22098

0.93

0.90

5.9

4.8

mmol/l

6.6

6.0

34.62

2015

20037

(3043238) Trisomy 21 risk [Likelihood] in Fetus

129

0.54

0.88

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.94

0.84

1.0

2.3

umol/l

15.6

18.9

—

(4094501)

668

0.80

0.84

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

1.78

0.84

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

275

1.31

0.82

1.3

nmol/l

—

(3000285) Sodium [Moles/volume] in Blood

1.88

0.81

1.2

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.70

0.80

1.1

1.4

—

127.3

—

(3006270) Folate [Moles/volume] in Blood

181

1.38

0.79

1.4

1.2

nmol/l

251.5

370.1

1.76

161

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.73

0.79

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.73

0.79

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.73

0.79

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.73

0.79

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.67

0.78

1.3

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.53

0.78

2.0

1.2

—

69.6

—

(3034426) Prothrombin time (PT)

1.62

0.78

1.9

1.3

—

(3005033) Fetal Nuchal fold Thickness US

125

0.56

0.77

1.4

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

126

0.55

0.77

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.77

0.76

1.0

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

1.57

0.75

1.0

1.1

u/ml

0.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.67

0.74

1.0

1.3

—

(40758292) HTLV I+II Ab panel - Serum

1.84

0.73

1.1

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.75

0.71

1.0

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

146

1306

1.12

0.69

1.2

iu/ml

134.4

158.1

0.27

477

(3051101) Glucose [Moles/volume] in Cord blood

1.63

0.66

18.3

5.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

614

1.18

0.66

1.4

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

137

1.39

0.64

1.5

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

579

1.18

0.64

1.5

1.7

e6/l

14786.6

14251.9

0.03

411

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

1.48

0.64

15.2

11.6

mmol/l

0.6

0.07

(3017446) Testosterone [Moles/volume] in Serum or Plasma

152

1679

0.90

0.62

2.0

2.2

nmol/l

13.4

12.8

0.29

141

1470

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2165

21380

1.06

0.61

34.8

14.0

ml/min/173m2

75.7

78.1

4.46

1940

17688

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.59

0.61

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

105

0.57

0.61

2.0

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.67

0.61

2.2

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

139

0.65

0.60

1.1

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

2.3

—

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

140

0.64

0.60

5.6

6.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

148

1.35

0.59

2.3

1.8

—

(3044290) Cell count panel - Cerebral spinal fluid

436

1.20

0.59

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

219

1.28

0.58

1.2

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

185

0.70

0.58

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

208

0.72

0.58

3.7

4.8

u/ml

22.8

50.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1029

0.88

0.56

1.1

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.57

0.56

1.8

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.55

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

148

0.67

0.55

1.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

547

0.84

0.55

1.3

1.5

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

126

0.63

0.54

1.6

1.3

—

1.5

—

(4034850)

758

0.87

0.52

17.9

9.6

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.43

0.52

1.4

1.3

102.9

108.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.43

0.52

1.0

1.2

—

9.7

—

(3005570) Glucose [Moles/volume] in Urine

233

1.25

0.51

2.3

2.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.42

0.50

3.2

1.9

ug/l

19.2

103.6

0.50

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

118

1.36

0.50

8.1

5.9

u/ml

186.1

49.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

271

2883

0.93

0.50

1.4

—

(4027681)

108

0.65

0.48

1.3

1.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

109

0.64

0.48

19.0

12.1

nmol/l

920.7

856.3

—

104

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.52

0.48

31.6

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

2021

19969

1.05

0.48

42.0

16.0

36.2

39.5

39.15

1390

13669

(40768795) Lymph node Pathology biopsy report

217

1.25

0.48

1.4

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

176

0.74

0.46

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

198

0.76

0.45

1.1

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

201

1.25

0.45

1.5

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

563

1.14

0.44

2.7

2.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

220

1.23

0.43

1.3

u/l

38.6

31.5

0.31

178

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.43

0.42

4.9

4.0

mg/l

5.4

7.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.56

0.42

1.6

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.42

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.36

0.41

1.2

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.41

1.0

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.41

0.0

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.2

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.3

—

18.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

0.00

0.41

0.0

1.3

—

43.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

334

1.17

0.39

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

270

0.81

0.39

1.6

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

113

1228

0.92

0.38

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

647

1.12

0.38

1.4

iu/l

29.6

32.9

0.39

549

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.31

0.37

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.43

0.35

1.5

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

117

1.28

0.35

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.36

0.34

1.3

3.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

318

0.85

0.33

4.1

4.8

umol/l

327.8

357.0

0.72

279

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.28

0.32

1.2

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

143

0.77

0.32

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

101

1.29

0.31

2.2

2.1

umol/l

55.0

55.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

312

2997

1.05

0.31

4.9

4.6

32.1

32.6

0.36

261

1975

(3003888) Timothy IgE Ab [Units/volume] in Serum

268

1.16

0.30

1.0

u/ml

1.5

3.2

1.21

133

(3032773) Endomysium IgG Ab [Titer] in Serum

166

1.21

0.29

1.2

1.0

titre

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.23

0.29

1.1

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

116

0.78

0.27

1.0

1.3

mmol/l

6.3

6.2

—

110

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

613

0.91

0.25

1.8

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.18

0.24

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.32

0.23

1.8

1.6

—

(3015183) Erythrocyte sedimentation rate

0.74

0.22

1.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.19

0.21

1.2

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

0.5

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

547

1.08

0.20

1.6

1.7

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.20

0.0

5.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.20

0.0

2.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.22

0.20

1.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

115

0.78

0.20

1.8

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.20

0.19

1.3

1.1

—

0.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.21

0.18

2.7

1.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.22

0.17

2.5

1.3

—

(3012565) Volume of 24 hour Urine

120

1.17

0.16

1.9

2.5

2559.3

1860.5

1.02

105

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.14

0.16

1.0

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

273

1.10

0.16

1.3

mmol/l

10.3

7.5

2.07

198

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.13

0.16

1.0

1.1

—

(3003338) MCHC [Mass/volume]

1839

18491

0.98

0.15

49.7

19.4

g/l

330.4

332.2

10.83

1826

18348

(3010144) Erythrocytes [#/volume] in Synovial fluid

226

1.11

0.15

1.3

1.4

e6/l

26924.1

59141.5

0.50

158

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

159

1.13

0.15

2.8

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

106

1102

0.96

0.13

1.5

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

146

1504

0.97

0.12

2.5

2.4

au/ml

59.1

22.8

—

(44813793)

134

0.90

0.08

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.84

0.07

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.05

0.07

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

112

0.89

0.07

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

122

0.90

0.07

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

133

1356

0.98

0.06

1.3

au/ml

28.3

60.3

—

(3006462) Nitrate [Presence] in Urine

104

0.86

0.06

1.7

3.5

—

(40761511) CBC panel - Blood by Automated count

2317

23206

0.99

0.06

36.0

14.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

199

1.06

0.04

1.0

u/ml

1.6

2.6

0.27

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

308

1.04

0.04

1.1

u/ml

0.8

1.5

0.66

132

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2397

23945

1.01

0.04

29.2

10.6

u/l

36.9

25.9

29.35

2374

23045

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

118

0.93

0.02

1.1

—

11.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

140

1413

0.99

0.02

1.3

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

319

0.97

0.02

1.2

1.1

—

11.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

431

1.02

0.02

1.6

1.7

—

(3008898) HLA-B27 [Presence]

638

0.99

0.01

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

263

1.03

0.01

1.0

u/ml

0.4

1.3

—

119

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

607

0.99

0.01

1.6

1.3

—

(3023410) Appearance of Cerebral spinal fluid

214

1.03

0.00

1.4

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

181

0.99

0.00

1.1

u/ml

1.4

4.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

475

0.99

0.00

1.5

1.4

e6/l

14.3

31.4

0.56

365

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

475

0.99

0.00

1.6

1.4

e6/l

661.4

1499.2

0.58

389

(4211845)

114

0.96

0.00

2.5

3.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

244

0.98

0.00

1.0

u/ml

0.5

3.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

262

0.99

0.00

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

518

1.00

0.00

1.4

1.8

iu/l

9.4

4.8

0.61

164

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

569.7

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

7.8

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

36.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

2.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.7

—

1.4

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.0

—

4.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

260

1.00

0.00

1.1

—

(3020650) Glucose [Presence] in Urine

0.95

0.00

1.3

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.95

0.00

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_FIBROCHIRLIV and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_FIBROCHIRLIV	4.932 [4.37, 5.57]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.028

During the follow-up period (1.1.1998 — 31.12.2019), 2888 out of 6837 females with K11_FIBROCHIRLIV died.

Males

Parameter	HR [95% CI]	p-value
K11_FIBROCHIRLIV	7.217 [6.12, 8.51]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3915 out of 6725 males with K11_FIBROCHIRLIV died.

Mortality risk

Mortality risk for people of age

years, who have K11_FIBROCHIRLIV.

N-year risk	Females	Males
1	0.42%	1.153%
5	2.374%	6.99%
10	6.022%	16.152%
15	11.499%	29.88%
20	19.055%	47.457%

Relationships between endpoints

↥

Index endpoint: K11_FIBROCHIRLIV – Fibrosis and cirrhosis of liver

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Fibrosis and cirrhosis of liver

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints